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Abstract
It has been found that β-hydroxyketone compounds can be reduced to the
corresponding 1,3-diol through an intramolecular carbonyl hydrosilation. Furthermore,
because this hydrosilation proceeds through a cyclic 6-membered ring transition state, this
reduction can be performed diastereoselectively by placing a stereocenter on the 6-membered
ring transition state. Prior to further investigations into this diastereoselective intramolecular
carbonyl hydrosilation, a streamlined synthesis of β-hydroxyketone compounds has been
developed. This new synthesis features an enone diboration/oxidation sequence found to be
successful on a broad scope of enones in high yields. Further studies have shown that
placing a stereocenter outside of the transition state ring invokes moderate levels of
diastereoselectivity based on the Felkin-Ahn model of carbonyl addition. However, when
stereocenters are placed both inside and outside of the transition state ring, as in the case of
the matched and mismatched hydrosilations, diastereoselectivity is based solely off of the
stereocenter inside of the transition state ring. This stereocontrol allows for the synthesis of
antipropionate subunits with both anti-syn and syn-syn stereochemistry. The synthetic utility
of this hydrosilation is shown by using this reaction to synthesize the stereocenters present in
the highly studied natural product discodermolide.
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1. Carbonyl Reduction
The reduction of a carbonyl to a primary or secondary alcohol is a commonly used
reactions in organic synthesis. Many molecules, from simple precursor molecules to
complex natural products and drugs contain alcohol functional groups. Reducing a carbonyl
is a very common technique to install this alcohol functionality. A carbonyl reduction can be
seen as adding a molecule of H2 across the carbon oxygen double bond (Scheme 1-1). This
type of reduction is called a hydrogenation and is usually performed in the presence of a
catalyst such as palladium or nickel with a carbon support.1 A reduction is usually signified
by placing ‘[H]’ above the reaction arrow (Scheme 1-1).
Scheme 1-1. Carbonyl hydrogenation with a palladium or nickel catalyst on a carbon support

1.1 Metal Hydride Reduction of Carbonyls
A more commonly used technique for the reduction of a carbonyl is the addition of a
hydride to the carbonyl followed by protonation of the oxygen (Scheme 1-2).1 A hydride is a
hydrogen atom with two electrons and a formal negative charge. Many hydride sources have
been developed for this purpose. Examples of commonly used hydride sources are lithium
aluminum hydride (LiAlH4), sodium borohydride (NaBH4), and lithium borohydride
(LiBH4).2 The mechanism for this type of reduction starts with the hydride adding into the
carbonyl carbon. This pushes the electrons from the pi bond of the carbonyl onto the oxygen

creating an oxygen anion. The next step is the protonation of the oxygen anion through an
aqueous workup to create the desired alcohol (Scheme 1-2).1
Scheme 1-2. Hydride reduction of a carbonyl with mechanism

The hydride species used in these reductions are often very reactive, containing a
formal negative charge on the metal delivering the hydride.2 These reactive hydride species
can often cause difficulty when trying to reduce a carbonyl on a molecule with other
functional groups present. It is important to take into consideration whether the other
functional group will be reduced as well. An example of this is the attempted reduction of
cyclopent-2-enone 1 to cyclopent-2-en-1-ol 3 using NaBH4 as the reducing agent. Rather
than only reducing the carbonyl, NaBH4 is capable of reducing alkenes as well, so the
substrate is reduced at both the carbonyl and the alkene yielding cyclopentanol 2 as the
product (Scheme 1-3).3
Scheme 1-3. Unselective reduction of cyclopent-2-enone

2

It is important to know which reducing agent to use with complex molecules
containing multiple functional groups. Table 1-1 shows a few common reducing agents
along with the functional groups that they are capable of reducing. Lithium aluminum
hydride (LiAlH4) is the strongest reducing agent of the reagents shown. It is able to reduce
all carbonyl groups as well as other function groups. Sodium borohydride (NaBH4) and
lithium borohydride (LiBH4) are structurally very similar, but switching cations from sodium
to lithium increases the reducing ability of LiBH4 in certain polar solvents such as
tetrahydrofuran (THF) and diethylether (Et2O). Borane (BH3) is commonly used as its THFor Me2S- derivative and is often used to reduce carboxylic acids and amides. Borane itself is
unable to reduce amides, but when the borane complexes with another reagent such as
tetrahydropyran it is then capable of the reduction. Borane is also commonly used for alkene
reductions. DIBAL-H is a useful reagent for reducing carbonyls because of its slightly
milder conditions and ability to reduce an ester to its corresponding aldehyde without further
reduction.2
Table 1-1. Common reducing agents and their reactivity towards various function groups

3

Some examples of reductions using these reagents are shown below (Scheme 1-4).
The first example demonstrates a sodium borohydride reduction chemoselectively reducing a
ketone in the presence of an alkene and two esters.4 The second example shows an amide
being reduced with a borane complex. In this case the borane (BH3) complexes with the
reagent, tetrahydropyran, to make the active reducing species.5 The third example shows the
ability of DIBAL-H to reduce esters to aldehydes and stop at the aldehyde without further
reduction to the alcohol.6

In the case of both borane and DIBAL-H, the hydride bearing metal is neutrally
charged. In order for the hydride to become reactive, the reducing agent must be activated.
This activation can be from another reagent in the reaction mixture such as a solvent or from
the substrate itself. In the example above (Scheme 1-4), borane is activated by the reagent
tetrahydropyran (THP). The oxygen on tetrahydropyran adds into borane giving the boron a
4

formal negative charge and allowing for transfer of the hydride.5 DIBAL-H is activated by
the substrate (Scheme 1-5). The carbonyl oxygen of the ester adds into the aluminum of
DIBAL-H giving it a formal negative charge. The hydride transfers to the carbonyl carbon
reducing the carbonyl.2
Scheme 1-5. Activation of DIBAL-H for reduction

1.2 Biological Hydride Source, NAD(P)H
Carbonyl reductions are also common to a number of important biosynthetic
pathways. Nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) or
nicotinamide adenine dinucleotide hydrogen (NADH) (Figure 1-1) are coenzymes that
provide hydrides for use by the body and other living organisms for biological functions. A
coenzyme is a moiety that is used by another enzyme for a certain function, in this case redox
reactions. The nicotinamide ring of NAD(P)H is the portion of the molecule that is involved
in accepting and releasing the hydride. These coenzymes can be seen in both the reduced
form, NAD(P)H, and the oxidized from, NAD(P)+. These coenzymes are involved in
numerous functions throughout metabolism, anabolism, and cell protection. Essentially all of
the controlled redox reactions that take place in the body use NAD(P)H as the hydride
acceptor or donor. An example of the function of NADPH in fatty acid synthesis is shown
below (Scheme 1-6).7
5

Figure 1-1. Structure of NADPH and NADH in both their reduced and oxidized form
Scheme 1-6. The role of NADPH in fatty acid synthesis

β-Ketothioester 4 is an intermediate in fatty acid biosynthesis. In the next step of this
pathway, the reduced NADPH donates a hydride from the nicotinamide ring by pushing the
lone pair of electrons on nitrogen up around the ring and forcing off the hydride which adds
to the ketone of 4 to create β-hydroxythioester 5 and the oxidized NADP+.2, 7
6

1.3 Stereoselective Reduction of Carbonyls
It is also possible to reduce a carbonyl stereoselectively. Stereoselective reductions
result in either a single enantiomer or diastereomer product. One example of a
diastereoselective reduction with L-selectride is shown below (Scheme 1-5). L-Selectride, or
lithium tri(sec-butyl)borohydride (Li(s-Bu)3BH), is a bulky hydride source, it contains three
large sec-butyl groups attached to the boron, creating a very hindered hydride. This steric
bulk allows the hydride to be selectively delivered to the least sterically hindered side of the
molecule.8 In the archazolid western hemisphere 7 synthesis, five different reducing agents
were tested to determine which gave the highest selectivity and yield (Table 1-2). It was
found that L-selectride would selectively add its hydride to one side of the ketone on 6 over
the other giving the proper western hemisphere 7 in a 10:1 ratio (Scheme 1-7).9 A method
for predicting this stereo control will be described in the next section.
Scheme 1-7. Example of L-selectride reduction

7

Table 1-2. Diastereoselectivity and yields of various reducing agents
Condition

Diastereoselectivity

Isolated Yield

NaBH4

3.1:1

78%

DIBAL-H

3.3:1

72%

LiAlH4

3.1:1

64%

LiB(Et)3H

20:1

46%

L-Selectride

10:1

73%

DIP-Cl is a chiral reducing agent that can be obtained as both the (+) and (-)
enantiomer. When used to reduce a carbonyl, the stereochemistry of the alcohol product
obtained depends on which enantiomer of DIP-Cl is used. The isopinocampheyl group on
the boron is derived from the natural product α-pinene (Scheme 1-8). α-Pinene can be
isolated from pine resin as well as resin’s from other coniferous plants and even a few nonconiferous plants. It occurs naturally in both the (+) and (-) enantiomers.10 Either (+) or (-)
DIP-Cl is synthesized depending on which α-pinene enantiomer is used. In this example
(Scheme 1-8), the ketone of 8 is reduced using the (-) enantiomer of DIP-Cl to give the
proper enantiomer of Singulair 9.11

8

Scheme 1-8. DIP-Cl reduction

These are just a few examples of the methods used to reduce carbonyls. There are
many different techniques to reduce carbonyls enantioselectively, diastereoselectively,
chemoselectively, under both mild and harsh conditions. The method chosen to reduce a
carbonyl is very substrate dependent. A reagent that is successful on one substrate may not
work as well on another if it has different functional groups or is less stable. It is important
to note that the majority of metal hydride carbonyl reductions proceed under harsh conditions
that could be detrimental to less stable substrates. This is especially a concern when it comes
to natural product synthesis, where fragments may become less stable and more reactive as
more functional groups are added.
1.4 Predicting Stereochemistry for Diastereoselective Reductions
A widely used model to predict the diastereoselectivity of nucleophilic attack to a
carbonyl is the Felkin-Ahn model. The Felkin-Ahn model has been refined over the years
including computational analyses by Ahn and Einstein.12 An important addition to this
model is the inclusion of the Burgi-Dunitz trajectory of attack where the nucleophile adds to
9

the carbonyl carbon at an angle of 107° from the oxygen.13 The Felkin-Ahn model predicts
that a nucleophile, or the hydride in the case of reduction, will add to the carbonyl opposite
of the large group and across the small group (Scheme 1-9). Very high diastereoselectivity
can be obtained depending on the relative size of the three groups (where RL = RLarge, RM =
RMedium, and RS = RSmall). In this example (Scheme 1-9), RL is a phenyl group (10) compared
to RM being a methyl group and RS being a hydrogen and the reduction occurs in a 98:2 ratio
of diastereomers favoring the Felkin predicted anti-product 11.14
Scheme 1-9. Felkin-Ahn model with example14

The Felkin-Ahn model is not accurate at predicting all nucleophilic additions to
carbonyls. In the case of α-amino and α-hydroxyl compounds, the Felkin-Ahn will not
always give the correct stereochemistry for the product.15 In these compounds, the metal will
chelate to the carbonyl and the α-amino or α-hydroxy group of the molecule creating a five
membered ring transition state keeping the carbonyl and the α-amino or α-hydroxy group
eclipsed. The nucleophile will then add to the carbonyl from the side of the smaller group
(Scheme 1-10). In the example below, there is an alcohol alpha to the aldehyde in 12. When
the nucleophile adds into the aldehyde, the metal chelates to the aldehyde and hydroxyl
group in transition state 14 forming a five membered ring. This complex allows the

10

nucleophile to add into the less hindered side giving the syn-product 13. This model was
proposed by Cram in 1959 and is called the Cram Chelate model.15
Scheme 1-10. Cram Chelate model with example.
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2. Carbonyl Hydrosilation
2.1 Hydosilation as an alternative to Main Group Metal Hydrides
Hydrosilation is a reduction method using silicon-based hydrides called
hydridosilanes, or hydrosilanes. It is a powerful reduction method and can be used to reduce
alcohols, aldehydes, ketones, amides, esters, etc.16 One advantage of using a hydrosilation
reduction over other metal mediated reduction methods is that it typically proceeds under
much milder conditions.16 This becomes more important when working with less stable
substrates such as in natural product synthesis. Another major benefit of the mild conditions
of hydrosilations is that it can selectively reduce a certain functional group in the presence of
other sensitive functional groups, such as epoxides, ketals, etc.16
Hydridosilanes are organosilicon compounds with at least one silicon-hydrogen bond.
They can be called hydridosilanes, hydrosilanes, or simply just silanes. These silanes have
properties similar to their hydrocarbon analogs and are generally not as reactive as other
metal hydride sources, allowing them to serve as mild air and often water stable hydride
sources. The bond strength of the silicon hydrogen bond is slightly weaker than its
corresponding carbon hydrogen bond, but essentially the same (Figure 2-1). Trimethylsilane
or triethylsilane having bond dissociation energies of 90.3 kcal/mol17 and 90.1 kcal/mol18
respectively, compared to the corresponding carbon-hydrogen bond with dissociation energy
of about 92 kcal/mol.17 The most important factor that allows silanes to serve as a hydride
source is the difference in electronegativity of silicon and hydrogen vs. carbon and
hydrogen.19 The electronegativity of carbon is 2.5, hydrogen is 2.2 and silicon is 1.9.20 In
12

the carbon-hydrogen bond, the bond is polarized towards carbon giving the hydrogen a slight
positive charge and causing it to act more as a proton. In the silicon hydrogen bond, the bond
is polarized towards hydrogen, giving the hydrogen a slightl negative charge and allowing it
to act as a hydride source (Figure 2-1).
Figure 2-1. Bond dissociation energy and polarity differences between Si-H and C-H

2.2 General Mechanism
Tetravalent silane reagents are neutral and lack the nucleophilicity that the majority of
metal-based reducing agents possess. Therefore, the atomic center being reduced must be
sufficiently electron deficient in order for hydride transfer to occur. This also allows for the
possibility of highly selective reductions using organosilicon hydrides. There are two
general routes for the reduction mechanism, the -route and the -route.16 In both cases, the
atomic center being reduced is electron deficient. The -route is denoted as that because of
its stepwise cleavage of a -bond to the corresponding carbocation followed by hydride
addition to that carbocation to produce the reduced product (Scheme 2-1). In the -route, the
-bond being cleaved is generally from a carbon to a good leaving group (X) and the leaving
group leaves before the hydride is added.

13

Scheme 2-1. -Route mechanism

In the -route, the hydride is added to a -bond. The double bond being reduced can
be either an alkene, carbonyl, imine, or thioketone. Again, the atomic center being reduced
must be electron deficient, so in this mechanism a Lewis acid interacts with one side of the
double bond allowing for a resonance structure with the other side bearing a carbocation.
The hydride will then add into the carbocation to give the reduced product (Scheme 2-2).
Further, it is possible for a molecule to go through the -route of reduction and sequentially
through the -route to give the double reduced product, generally a methylene group.
Scheme 2-2. -Route mechanism

2.3 Ketone Hydrosilation
The silane-mediated reduction of ketones to their corresponding secondary alcohol
can be performed under a variety of conditions including acid and base catalyzed condition
and transition metal catalyzed conditions. It is also possible to reduce ketones
diastereoselectively and chemoselectively depending on the reagents used. Below are
examples of organosilicon hydride reductions of ketones under various conditions.
14

An example of a Lewis-acid mediated ketone hydrosilation is the reduction of
cyclohexanone 15 to cyclohexanol 16. This hydrosilation can be performed in 74% yield
using 3.0 equivalents of both triethylsilane (Et3SiH) and trifluoroacetic acid (TFA) for 24
hours at 55° C followed by an aqueous potassium carbonate (K2CO3) workup (Scheme 2-3).
This reaction follows the -route mechanism by having TFA act as the Lewis acid,
interacting with the carbonyl of 15, followed by addition of the hydride.21
Scheme 2-3. Ketone reduction by triethylsilane and trifluoroacetic acid21

It is also possible to do the double reduction of a carbonyl down to the methylene
subunit (Scheme 2-4). The following example is also a Lewis-acid mediated reduction. In
this example, adamantanone 17 is reduced by 2.2 equivalents of triethylsilane and boron
trifluoride (BF3) all the way down to adamantane 18. In the first step of the reaction, the
Lewis-acidic boron trifluoride interacts with the carbonyl oxygen of 17 to increase the
electron deficiency of the carbonyl carbon. The first equivalent of triethylsilane reduces the
carbonyl to the intermediate 19 and the byproduct triethylsilyl fluoride. It is then unknown
whether or not a second equivalent of BF3 adds to the oxygen followed by hydride addition,
or whether the OBF2- leaves, leaving a carbocation before the second equivalent of hydride is
added. In either situation, the carbon is reduced for a second time leaving the fully reduced
product 18 in quantitative (100%) yield (Scheme 2-4).22
15

Scheme 2-4. Double reduction of adamantanone to adamantane using Et3SiH22

When going through a Lewis-base mediated mechanism, it is common for a
pentavalent silicon intermediate with a formal negative charge on silicon to be formed. This
pentavalent silicon species is allowed because silicon is in the third row of the periodic table
and has access to its d-orbitals to form expanded octets. These pentavalent organosilicon
hydride species have increased nucleophilicity and can react with ketones that have not been
previously activated by a Lewis acid. Similar to how borane and DIBAL-H are activated
before their hydride is transferred; hydridosilanes can also be activated prior to reduction. In
this example, 2 equivalents of dilithiated catechol 20 react with trichlorosilane to form the
pentavalent silane intermediate 21. The pentavalent silane intermediate 21 then reduces
benzaldehyde at 0° C to give benzyl alcohol 22 in 95% yield (Scheme 2-5).23
Scheme 2-5. Lewis-base mediated hydrosilation of benzaldehyde23
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In the transition metal catalyzed hydrosilation, the nucleophilicity of the hydride is
increased by the metal inserting itself into the silicon hydrogen bond to give a metal hydride
source. In this example, cyclohexanone 23 is reduced to triethylsilyl (TES) protected
cyclohexanol 24. This reaction can be useful in synthesis because it reduces the carbonyl and
TES protects it all in one step, whereas this would normally be a two-step process to reduce
the carbonyl in the first step and TES protect it in the second. In this case, copper(I) chloride
is used with an N-heterocyclic carbene ligand 25 (Scheme 2-6). The catalytic cycle for this
reaction is shown (Scheme 2-7). The metal catalyst 26 inserts itself into the silicon hydrogen
bond via oxidative addition to give the metal hydride source 27. The ketone then comes in
and goes through a -bond metathesis with the metal hydride 27 to form the metal alkoxide
28. The metal alkoxide goes through a reductive elimination to form the TES protected
alcohol product 29 and reform the active catalyst 26.24
Scheme 2-6. Transition metal catalyzed hydrosilation of cyclohexanone24
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Scheme 2-7. Mechanism for the transition metal catalyzed hydrosilation24

Hydrosilations can be performed with high diastereoselectivity in certain situations.
In the case of 4-tert-butylcyclohexanone 30, the ketone can be reduced using a large silane
reagent, tristrimethylsiloxysilicon hydride 33 ((Me3SiO)3SiH), in a ratio of 99:1 trans 31 to
cis 32 (Scheme 2-8). The selectivity for this reaction is provided by the large size of the
(TMSO)3SiH group. The t-butyl substituent on cyclohexanone is large enough to essentially
be locked in the equatorial position. The size of the silane reagent forces it to add its hydride
axially to the carbonyl, pushing the alcohol into the equatorial position 34 (Scheme 2-8). In
this case, the diastereoselectivity is based solely on steric hindrance of the silane reagent 33
and the large t-butyl substituent being locked in the equatorial position. If either the
substituent or the silane reagent were not as bulky, the diastereoselectivity would be
affected.25
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Scheme 2-8. Diastereoselective hydrosilation of 4-tert-butylcyclohexanone25

It is also possible to perform diastereoselective hydrosilations via a proton bridged
Cram-cyclic model, a variation of the Cram-chelate model.15 Hiyami and coworkers have
shown that it is possible to synthesize the cis isomer of various 2-amino alcohols, 1,2-diols,
and 3-hydroxyalkanoic acid derivatives26-28 using this Cram-cyclic model. The amino or
alcohol group forms a proton-bridge to the carbonyl and the methyl group alpha to the
carbonyl directs the hydride addition (Scheme 2-9). This often gives selectivities of >99:1 in
high yields (Scheme 2-9).28
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Scheme 2-9. Diastereoselective hydrosilation via Cram-cyclic model to form cis products28

It is also possible to form the trans selectivity using F- as a reagent for the
hydrosilation instead of an acid with the same PhMe2SiH silane reagent. The mechanism for
this reaction follows the Felkin-Ahn model to determine selectivity (Scheme 2-10). Again,
these compounds are reduced in high yields and excellent diastereoselectivities (Scheme 210).26
Scheme 2-10. Diastereoselective hydrosilation via Felkin-Ahn model to form trans
products26
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Chemoselective hydrosilations are also possible depending on the reagents used. A
chemoselective reaction affects only one functional group in the presence of others. Plietker
and coworkers found an iron catalyst that can chemoselectively reduce an aldehyde in the
presence of other functional groups using polymethylhydrosiloxane (PHMS) as the silane
reagent. This catalytic system is capable of selectively reducing aldehydes in the presence of
alkenes (Scheme 2-11).29 In the first example, the aldehyde 35 is reduced chemoselectively
using PHMS, Bu3N[Fe(CO)3(NO)] (TBAFe) as the iron catalyst and PCy3 as the additive in
1,4-dioxane followed by a basic workup to give the corresponding primary alcohol 36 in
96% yield without touching either of the alkenes. The second example is from Beller and
coworkers who found a method to chemoselectively reduce the ketone 37 in the presence of
alkenes using PMHS as the silane reagent, Fe(OAc)2 as the catalyst and PCy3 as the additive
to give the corresponding secondary alcohol 38.30
Scheme 2-11. Chemoselective aldehyde reduction using an iron catalyst and PHMS29, 30

It is important to pay attention to the conditions being used when attempting a
chemoselective hydrosilation because not all silane reagents are chemoselective. In the
example below, the ketone is reduced, but 2 other alkenes are also reduced in the reduction of
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1α,11-(2-oxethano) thioketal steroid 40 with excess triethylsilane and TFA giving the triple
reduced product 41 (Scheme 2-12).31
Scheme 2-12. Hydrosilation of 1α,11-(2-oxethano) thioketal steroid with excess Et3SiH31
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3. Previous Hydrosilation Results
3.1 Original Project Goals
The previous work on this project was performed by Kyle Carter and Michael Miller
under the direction of Dr. Gregory W. O’Neil. Their work was published in Organic Letters
in 2010 titled Direct Conversion of β-Hydroxyketones to Cyclic Disiloxanes.32 The original
goal of this project was to first synthesize β-hydridosiloxyketone compounds 43 from their
corresponding β-hydroxyketones 42 and then develop conditions for an enantioselective
intramolecular carbonyl hydrosilation to generate the corresponding enantioenriched cyclic
disiloxane 44 (Scheme 3-1). An intramolecular carbonyl hydrosilation is a reduction of a
ketone where the hydride on silicon is tethered to the substrate. Once the ketone is reduced,
the negatively charged oxygen adds back to silicon forming the cyclic disiloxane product.
From there, it would be possible to remove silicon to access various propionate subunits. A
propionate subunit is defined as a molecule with alternating methyl and hydroxyl groups on
adjacent carbons of the backbone. These propionate subunits are common to a large number
of important natural products. Highlighted below are just a few examples of natural products
in which these propionate subunits can be found including scytophycin C33, bourgeanic
acid34, zincophorin35, and discodermolide36 (Scheme 3-2).
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Scheme 3-1. Intramolecular carbonyl hydrosilation of β-hydroxyketones
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Scheme 3-2. Various natural products with propionate subunits highlighted

3.2 Substrate Synthesis and Scope of Reaction
The first step in this project was to create the β-hydroxyketone compounds required
for further studies. 3-Hydroxy-1-phenylpropan-1-one 46 was the first β-hydroxyketone
synthesized because it could be made in a single step by free radical oxidation of 3phenylpropan-1-ol 45 (Scheme 3-3) which was accomplished in 50-70% yield. From there,
the hydroxyl group was silylated with either i-PrSiHCl or t-BuSiHCl in the presence of
imidazole at 0° C to create the corresponding β-hydridosiloxyketones 47 and 48. This
reaction was straight forward and accomplished in 70-80% yield (Scheme 3-3).
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Scheme 3-3. Synthesis of β-hydridosiloxyketone compounds from 3-phenylpropan-1-ol

However, when Ph2SiHCl was used to create the β-hydridosiloxyketone 49, a small
amount (<10%) of the corresponding cyclic disiloxane 50 was formed (Scheme 3-4). It was
assumed that a small amount of the β-hydridosiloxyketone 49 had gone through an
intramolecular carbonyl hydrosilation under these conditions to reduce the ketone and form
the 6-membered disiloxane ring. This was unexpected as it did not happen with the synthesis
of the two previous β-hydridosiloxyketones 47 and 48 and it usually requires additional
conditions to promote hydrosilation. With this result, the cause of the hydrosilation was
investigated. Knowing that hydrosilation reactions could be acid promoted, the first thought
was that the small amount of HCl produced from the alcohol adding into the silane was
catalyzing the hydrosilation.
Scheme 3-4. Small amount of cyclic disiloxane formation upon addition of silane

Anwar and Davis have shown that a similar intramolecular carbonyl hydrosilation can
be catalyzed by the addition of a Lewis acid. They attempted various Lewis-acid catalysts
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such as tin chloride (SnCl4), magnesium bromide etherate (MgBr2•Et2O), titanium chloride
(TiCl4) and boron trifluoride etherate (BF3•Et2O). All of the catalysts were successful in the
intramolecular carbonyl hydrosilation to form the cyclic disiloxane, but some attained better
diastereoselectivity than others (Scheme 3-5). Using 10 mol-% of SnCl4 attained a
diastereomeric ratio of 120:1 anti: syn with a 67% yield.37
Scheme 3-5. Intramolecular carbonyl hydrosilation with various Lewis-acid catalysts37

Additional acid catalysts were therefore screened in an attempt to increase the
conversion of 49 to cyclic disiloxane 50. The proposed mechanism for this intramolecular
carbonyl hydrosilation would be similar to that proposed by Anwar and Davis. It was
thought to proceed through a cyclic 6-membered transition state 51 with a Lewis acid
activating the carbonyl for hydride transfer. Once the hydride is transferred, the anionic
oxygen adds into the silicon group creating the cyclic disiloxane product 50 (Scheme 3-6).
When these acid-mediated hydrosilation conditions were attempted with the mixture of βhydridosiloxyketone 49 and <10% cyclic disiloxane 50, the major product obtained was only
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reformation of the β-hydroxyketone starting material 46 (Scheme 3-7). Various Lewis acids
were screened including BF3•Et2O, MgBr2•Et2O, pyridinium paratoluene sulfonate (PPTS),
camphorsulfonic acid (CSA), (PhO)2P(O)OH, and imidazole·HCl.
Scheme 3-6. Proposed transition state

Scheme 3-7. Lewis acid screening

Addition of a Lewis acid did not increase the conversion to cyclic disiloxane F.
Addition of amine bases to the reaction mixture were screened next It turned out the addition
of either triethylamine (Et3N) or Hünig's base (N,N-diisopropylethylamine, i-Pr2NEt) greatly
increased the conversion to the cyclic disiloxane. Conveniently, it turns out that the silyl
addition and intramolecular carbonyl hydrosilation to form the cyclic disiloxane can be done
in one step rather than two. Attempted isolation of the cyclic disiloxane product by column
chromatography on silica gel proved troublesome, as they are prone to decomposition on
silica. However, isolation by column chromatography using Florasil yielded better success,
providing cyclic disiloxanes 50 and 53 in 47% and 42% yields respectively (Scheme 3-8).
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Desilylation with tetrabutylammonium fluoride (TBAF) in THF provided the 1,3-diol
product. Furthermore, desilyation is possible without isolation of the cyclic disiloxane. To
prove that the cyclic disiloxane product isolated from the β-hydroxyketone was the correct
product, silylation of the 1,3-diols 54 and 55 with diphenyldichlorosilane (Ph2SiCl2) and
imidazole provided the cyclic disiloxane product and the characterization data were
compared and found to match. Overall, it is more successful to perform the intramolecular
carbonyl hydrosilation and promptly desilate without isolation of the cyclic disolxane to form
the 1,3-diol product.
Scheme 3-8. Amine additives for hydrosilation promotion

Now that successful hydrosilation conditions had been discovered, the substrate scope
of this reaction was tested. The synthesis of the β-hydroxyketone starting material involved a
multistep sequence consisting of 5 steps and resulted in overall yields of 30-50% (Scheme 39). This multistep synthesis starts with an aldol reaction between an aldehyde 56 and ethyl
acetate in the presence of lithium diisopropylamide (LDA) to form the β-hydroxyester 57.
Next, the alcohol is oxidized using sulfuric acid and chromium trioxide (Jones’ reagent) to
give the β-ketoester 58. In order to selectively reduce the ester to the alcohol without
reduction of the ketone, the ketone must be protected as the acetal using ethylene glycol
giving the acetal protected ketone 59. Lithium aluminum hydride can then be used to
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selectively reduce the ester to the alcohol 60, followed by deprotection of the acetal under
acidic conditions to produce the corresponding β-hydroxyketone 61.
Scheme 3-9. Synthesis of β-hydroxyketone compounds

The substrate scope of the hydrosilation/desilylation to synthesize 1,3-diols was
tested on various β-hydroxyketones (Scheme 3-10). It was found that the majority of
substrates were successfully hydrosilylated to provide the corresponding 1,3-diol in good
yields from the low 60’s up to 76% 54, 55, 62-65. This hydrosilation is tolerant to aryl
groups 54 and 65, alkyl chains 55 and 62, α,β-unsaturated ketones 63 and 64, and even
electrons withdrawing substrates 65. There were a few substrates that proved troublesome in
this reaction, however. The t-butyl derived β-hydroxyketone 67 was isolated in only 32%
yield, but 75% based on recovered starting material (brsm). It seems that this reaction is
affected by the steric bulk of large R groups such as t-butyl groups, and this hinders the
ability of the hydride to transfer. Also, the p-methoxyphenyl derived β-hydroxyketone 68
proceeded in 42% yield (78% bsrm) showing that the electron donating properties of the
methoxy substituent decrease the electron deficiency of the carbonyl carbon making it less
likely to get reduced. Other interesting results include the hydrosilation of two α,β30

unsaturated β-hydroxyketone to give products 63 and 64 which were reduced in 65% and
70% yield respectively. These results show that this hydrosilation has high levels of
chemoselectivity for ketones over alkenes. In both cases, the alkene was not touched by the
hydrosilation. Lastly, the attempted hydrosilation of 4-hydroxybutan-2-one 66 provided no
success whatsoever. Likely the substrate is too unstable for the hydrosilation conditions.
Scheme 3-10. Substrate scope of hydrosilation/desilylation 1,3-diol synthesis

3.3 Mechanistic Studies
Mechanistic studies were performed to predict a mechanism for this hydrosilation.
Based on two studies, it was found that imidazole is essential for the hydrosilation to occur
(Scheme 3-11). The first study tested the hydrosilation on two substrates in the presence of
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Ph2SiHCl and Et3N with no imidazole and found that the only product formed was the βhydridosiloxyketones 49 and 69. Absolutely no hydrosilation had occurred. The second test
used N-methylimidazole in the place of imidazole and found that again, βhydridosiloxyketones 49 and 69 were the exclusive products of this reaction. Not only is
imidazole required for this reaction, but the hydrogen on the amine is also required.
Scheme 3-11. Hydrosilation in the absence of imidazole

The requirement for the β-hydroxy functionality was tested next. The first test simply
used ethyl ketone 70 under the usual hydrosilation conditions and achieved no reaction
(Scheme 3-12). The carbonyl had not reacted under the hydrosilation conditions when the βhydroxy functionality was not present. The second test looked at an α-hydroxy ketone 80 as
a possible hydrosilation substrate. It turned out that this reaction was slightly successful,
yielding the corresponding 1,2-diol 81 in 14% yield after desilylation (Scheme 3-12. But the
5-members transition state seems to be too small for high yielding hydrosilations to occur.

32

Scheme 3-12. Hydrosilation in the absence of the β-hydroxy functionality

The proposed mechanism for this hydrosilation occurs via nucleophilic activation
(Scheme 3-13). The first step is formation of the β-hydridosiloxyketone 83 by the addition
of the alcohol of 82 to Ph2SiHCl in the presence of imidazole. In the next step the
imidazole·HCl is deprotonated by the triethylamine to reform imidazole and form Et3N·HCl.
For the hydrosilation, there are two proposed transition states that could be possible, 84 and
85. In both proposed transition states, the silicon is activated by imidazole to create a
pentacoordinate silane with a more reactive hydride. Silicon activation by imidazole is well
known and has been studied through 29Si NMR by Stout and coworkers.38 The hydride then
adds to the carbonyl in a 6-membered chair-like transition state, 84 or 85, to form the cyclic
disiloxane product 86. In proposed transition state 84, imidazole activates silicon from the
bottom and the triethylamine interacts with the hydrogen on the other nitrogen of the
imidazole ring. In proposed transition state 85, imidazole activates silicon from the top, and
the hydrogen on the opposite side of the imidazole ring hydrogen bonds with the carbonyl
activating it even further. It is thought that the hydrosilation proceeds through proposed
transition state 84 because previous studies have shown triethylamine is required for
hydrosilation to occur, and triethylamine is not involved in 85.
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Scheme 3-13. Proposed mechanism for intramolecular carbonyl hydrosilation

3.4 Diastereoselective Hydrosilation
Having the hydrosilation occurrs through a 6-membered ring chair-like transition
state opens up the possibility for a diastereoselectively hydrosilation. A six membered ring
in the chair conformation prefers to have any substituents in the equatorial position because it
is the lower energy conformation and avoids steric strain from other groups on the ring.1
Adding a substituent to one of the carbons that are in the chair-like transition state ring 87
would cause that substituent to be preferentially in the equatorial position 89 which would
promote formation of a single diastereomer product 88 (Scheme 3-14).
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Scheme 3-14. Diastereoselective hydrosilation

Based on the transition state shown, the stereocenter would promote syn
stereochemistry in the product. Substrates with a methyl group on the carbon alpha to the
carbonyl 90-92 were synthesized to test this prediction and it was found that this methyl
group did in fact promote syn stereochemistry in the propionate product. These
hydrosilations proceeded in great yields, 76% to 91% and varied from 6:1 syn to anti
stereoselectivity all the way up to >10:1 (Scheme 3-15). Using this hydrosilation is a new
synthetic route to syn-propionate subunits.
Scheme 3-15. Proposed diastereoselective hydrosilation

35

Now that diastereoselectivity had been achieved by adding a stereocenter on the alpha
carbon inside of the transition state ring, we were curious whether or not diastereoselectivity
could be achieved from placing a stereocenter on the other side of the carbonyl 96. This
hydrosilation would most likely proceed through Felkin control 98.12 The hydride would add
in from the opposite side of the large ‘R’ group and past the hydrogen on this stereocenter to
give the cyclic disiloxane product 97 (Scheme 3-16). But before this hydrosilation was to be
tested, a quicker method for synthesis of the β-hydroxyketone starting material was sought
after.
Scheme 3-16. Diastereoselectivity hydrosilation via Felkin control12
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4. Diboration/Oxidation for Synthesis of β-Hydroxyketones
4.1 Proposed Synthesis
The proposed synthetic route for β-hydroxyketone starting material involves a
diboration and oxidation of a terminal enone to obtain the β-hydroxyketone product in two
steps from the enone, essentially saving three steps from the previous method (Scheme 3-9).
The new method will start with a 1,4-diboration of a terminal enone 99 to provide the βketoboronate ester 100 followed by oxidation of the carbon boron bond to provide the
corresponding β-hydroxyketone 101 (Scheme 4-1). The boron reagent used in this would be
bis(pinacolato)diboron 102 (B2pin2). The hydrosilation focuses on primary alcohol
substrates, so it is required that terminal enones are used in order to obtain the primary
alcohol required.
Scheme 4-1. Synthetic scheme for new β-hydroxyketone synthesis

The idea for using this diboration oxidation sequence came from the previous
research I had done in Dr. Timothy Clark’s lab. Dr. Clark’s lab has moved from Western
Washington University to University of San Diego. His research focuses on the addition of
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boron into organic substrates to produce organoboranes. My project involved a copper
catalyzed diboration of aldehydes and ketones. The (ICy)CuCl precatalyst used in this
diboration contained an N-heterocyclic carbene (NHC) ligand. The active (ICy)CuOt-Bu 106
catalyst was formed in situ from the addition of NaOt-Bu to the precatalyst. This catalyst
would add B2pin2 102 across the double bond of the carbonyl 103 to give the 1,2-diboration
product 104. The oxygen boron bond was hydrolyzed by filtration through a plug of silica
gel to yield the corresponding α-hydroxyboronate ester product 105.39
Scheme 4-2. Copper-catalyzed diboration of aldehydes and ketones followed by hydrolysis

Cameron Moore, another member of Dr. Clark’s group, had worked on a similar
project, the 1,4-diboration of α,β-unsaturated carbonyls. Diboration of cyclohex-2-enone 107
under the same catalytic conditions gave the 1,4-diboration product 108. After hydrolysis of
the 1,4-diboration product, β-ketoboronate ester 109 was obtained (Scheme 4-3). This
product is now one step away from β-hydroxyketone 102 which is similar to the desired βhydroxyketone 101 for hydrosilation. Seeing these results gave me the idea of using a
similar 1,4-diboration with terminal enones, followed by an oxidation to give the
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corresponding primary β-hydroxyketone. It was not practical to use the same (ICy)CuCl
catalyst from Dr. Clark’s research to synthesize the primary β-hydroxyketone compounds
because this catalyst is extremely air and water sensitive and requires the use of a glovebox.
Screening other 1,4-diboration catalysts would be required.
Scheme 4-3. 1,4-diboration of cyclohex-2-enone followed by hydrolysis

4.2 1,4-Conjugate Diboration Catalysts
1,4-Diboration of enones is relatively new with the first 1,4-diboration published in
1997. Since then, several other methods for this diboration have been published with the
general trend of milder reaction conditions and cheaper catalysts being used as the reaction is
further studied. The first 1,4-diboration proposed by Rice and coworkers in 1997 uses 5 mol% of a platinum catalyst, [Pt(C2H2)(PPh3)2], heated to 80° C for 12 hours using either B2pin2
102 or bis(catacholato)diboron 113 (B2cat2). The boron enolate product 111 is then
quenched with water to provide the β-ketoboronate ester 112 in 90% yield (Scheme 4-4).40
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Scheme 4-4. Platinum catalyzed diboration by Rice and coworkers40

The catalytic cycle for this reactions starts with the platinum catalyst 114 going
through an oxidative addition with the diboron reagent 102 or 113 (102 shown) to provide
platinum with two Bpin ligands on it 115. The platinum catalyst 115 then adds to the enone
to give the platinum enolate 116 containing the carbon boron bond desired. Reductive
elimination gives the 1,4-diboration product 111 and reforms the platinum catalyst 114
(Scheme 4-5).40
Scheme 4-5. Platinum catalyzed diboration catalytic cycle40
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Yun and coworkers discovered a copper (I) catalyzed diboration of enones using a
CuCl catalyst and NaOt-Bu additive. This catalytic system contains a proton source,
methanol, in the reaction mixture, so instead of producing the boron enolate, the enolate gets
protonated by methanol and the β-boration product 117 is produced (Scheme 4-6). This
diboration can be achieved asymmetrically by the addition of a chiral ligand. Using the (R)(S)-josiphos ligand 118, the product is formed in 97% yield and 97% ee (Scheme 4-6).41
Scheme 4-6. Copper (I) chloride catalyzed diboration and asymmetric diboration41

The catalytic cycle for this diboration was proposed by Oestreich and coworkers
(Scheme 4-7), and starts by combining CuCl and NaOt-Bu to form the CuOt-Bu precatalyst
119 which goes through a sigma bond metathesis with B2pin2 102 to form the copper-Bpin
active catalyst 120. Next, 120 adds into the alkene of the enone to form the carbon boron
bond on the beta carbon 121. Migration of copper occurs to form the copper enolate 122
which is subsequently protonated by methanol followed by a tautomerization to form the
desired β-ketoboronate ester product 124 along with copper methoxide 123. To reform the
active catalyst 120, 123 goes through a sigma bond metathesis with another equivalent of
B2pin2 102. The final sigma bond metathesis to reform the active catalyst 120 is proposed to
be the slow step and thus the rate determining step in this catalytic cycle.42
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Scheme 4-7. Catalytic cycle of copper catalyzed diboration42

Hoveyda and coworkers have discovered metal free conditions for enone diboration.
In this example they start with a disubstituted enone 125, which, because of sterics, is the
most unreactive enone to 1,4-diboration, and are able to diborate in 96% yield to produce a
quaternary carbon containing boron product 126 (Scheme 4-8). This reaction requires 2.5
mol-% of the NHC catalyst 127 and 2.5 mol-% of NaOt-Bu with 1.1 eq. of B2pin2 and goes
to >98% conversion in 6 hours. Under the same conditions, monosubstituted enones were
able to go to completion within one hour. The mechanism for this reaction starts with the
activation of the diboron reagent 102 by nucleophilic addition of 127 to one of the borons.
This forms an activated sp2-sp3 hybridized diboron reagent 128. The activated diboron
reagent then adds to the alkene of cyclic enone 129 to form diboron species 130. The
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nucleophile leaves the boron reagent and the boron migrates to the oxygen to form the boron
enolate 131. After an aqueous workup, the enolate is quenched to provide the β-boration
product (Scheme 4-8).43
Scheme 4-8. Metal-free 1,4-diboration and mechanism43

Knowing that the sp2-sp3 hybridized diboron reagent is more active than the sp2-sp2
hybridized diboron, Santos and coworkers created a novel diboron reagent called pinacolato
diisopropanolaminato diboron 132 (PDIPA) that contains an sp2 hybridized Bpin group and
an activated sp3 hybridized amino boron group (Scheme 4-9). Having this preactivated
diboron species helps speed up both rate determining sigma bond metathesis steps in the
mechanism, allowing faster formation of the active catalyst 120. (Scheme 4-7). This
catalytic system is capable of diborating the less reactive α,β-unsaturated ester 133 to give
product 134 in 96% yield (Scheme 4-9).44 This reaction follows a very similar catalytic cycle
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to that proposed by Oestreich and coworkers,42 the only difference being PDIPA is used in
place of B2pin2 and trifluoroethanol is used in place of methanol (Scheme 4-9).44, 45
Scheme 4-9. PDIBA diboration of α,β-unsaturated ester and catalytic cycle44

Recently, Yun and coworkers described a diboration that proceeds in an aqueous
environment under an N2 atmosphere. This diboration uses CuCl as the catalyst and NaOtBu as the additive in a 2:1 mixture of THF to H2O (Scheme 4-10). For the majority of
substrates tested, the reaction goes to completion in 1-3 hours for a variety of different
enones, including terminal enones, substituted enones, and α,β-unsaturated esters and amides.
Larger substituents on the enone decreased the conversion rate and stopped the reaction from
going to completion in less than 6 hours for some substrates.46
Scheme 4-10. Aqueous diboration under an N2 atmosphere46
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Santos and coworkers also described an aqueous diboration in an open air atmosphere
using a Cu(II) catalyst. In this mechanism, water activates the diboron reagent 102 and the
additive picoline 135 deprotonates the water (Scheme 4-11). The activated diboron then goes
through a transmetalation with copper to enter a similar catalytic cycle as above (Scheme 47) to yield the diboration product 136.47
Scheme 4-11. Aqueous Cu(II)-picoline diboration47
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5. β-Hydroxyketone Synthesis
5.1 Initial Diboration Results
The new proposed synthesis of β-hydroxyketone compounds C starts with a terminal
enone A that will go through a 1,4-diboration most likely with B2pin2 D to produce the βketoboronate ester B. The carbon boron bond of B will then be oxidized to provide the
corresponding β-hydroxyketone C in two steps from the terminal enone (Scheme 5-1) rather
than the five steps that it previously required from the corresponding aldehyde (Scheme 3-9).
Scheme 5-1. New synthesis of β-hydroxyketone compounds

The first step was to find conditions for enone diboration. Looking at all the
examples, this seemed to be a fairly straight-forward task. However, initial diboration
attempts were not successful (Scheme 5-2). The first attempted diboration followed metal
free conditions set forward by Fernandez and coworkers.48 Triphenylphosphine (PPh3) was
used as the catalyst and cesium carbonate (Cs2CO3), a strong base, was required for the
reaction. The PPh3 worked to activate B2pin2 for 1,4-addition to the enone and MeOH was
used as a proton source to protonate the enolate. Little to no diboration product was present
by 1H NMR analysis, and all starting material had been used up or decomposed. These
reaction conditions seem to be too harsh for the terminal enone substrates. Terminal enones
are not as stable as their substituted counterparts, and Cs2CO3 is a very strong base that could
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be causing decomposition. For the second attempt, these conditions were modified by
replacing Cs2CO3 with the milder amine base 1,8-diazabicycloundec-7-ene 137 (DBU).
However, these modified conditions turned out to be unsuccessful as well. Our final attempt
with these conditions used only DBU 137 as the catalyst in the hopes that it would be enough
to activate the diboron for 1,4-addition to the enone. This turned out to be unsuccessful as
well, sending us back to the literature to find a new procedure.
Scheme 5-2. Initial enone diboration attempts

After looking through various enone diboration protocols, it became clear that
terminal enone diboration has not been highly studied. Only two papers were found, each
with only a single example of a terminal α,β-unsaturated ketone being diborated. The first
example is from Yun and coworkers and used a CuCl and NaOt-Bu catalyst in THF and
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water46 (Scheme 5-3) and the second is by Santos and coworkers and performed in a
completely aqueous system with a Cu(II)SO4 catalyst and picoline base47 (Scheme 4-11).
The protocol Yun and coworkers was attempted first because of the ease of the catalytic
system. Using a benzaldehyde derived enone 138, Yun’s catalytic system was followed, and
at first looked to be very successful (Scheme 5-4). The 1H NMR of the product 139 was very
clean and all the proper peaks were present. A COSY spectra was taken to prove to
ourselves that this was indeed the product that we were looking for. By mass, it was a 97%
yield, but upon further inspection of the 1H NMR integrations, the singlet at ~1.2 that
represents the 12 hydrogens of the Bpin group was integrating to about 24 hydrogens,
approximately twice what it was supposed to. This over integration was most likely due to
unreacted B2pin2 still present in the final product. Purification by column chromatography
on silica gel was unsuccessful at removing this extra B2pin2 so the next step was to optimize
these reaction conditions.
Scheme 5-3. Example of terminal enone diboration46

Scheme 5-4. Successful diboration
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Before attempting to optimize the reaction conditions, it is important to understand
the reaction mechanism. This reaction proceeds through a copper catalyzed mechanism with
Cu-bpin as the active catalyst (Scheme 5-5).42 The first step is creation of the CuOt-Bu
precatalyst 119 from CuCl and NaOt-Bu. The precatalyst 119 goes through a sigma bond
metathesis with B2pin2 102 to form the active CuBpin catalyst 120. The active catalyst adds
to the alkene of the enone 99 to form the β-boration product 140, which is in resonance with
the copper enolate 141. Water protonates the enolate followed by tautomerization to from
the β-ketoboronate ester product 100 along with copper hydroxide 142. In the proposed ratedetermining step of the catalytic cycle, copper hydroxide goes through a sigma bond
metathesis with B2pin2 to reform the active catalyst 120.42, 46
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Scheme 5-5. Proposed catalytic cycle for the diboration of terminal enones42, 46

5.2 Optimization and Scope of Reaction
Enone 138 was used as the model substrate for optimization studies because it was
easy to synthesize and seemed to be stable and nonvolatile. Knowing that triphenyphosphine
helped to activate diboron reagents for addition,42, 48 the first optimization attempt involved
the addition of 20 mol-% of triphenylphosphine to the catalytic system (Scheme 5-6). This
did not lead to any improvement on the yield, but it did allow for isolation of the βketoboronate 139 ester with no B2pin2 contaminant, albeit in only a 35% yield. Knowing that
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terminal enones are not the most stable substrates, and could potentially be decomposing in
the reaction mixture, the starting enone was used in excess to the B2pin2. Using 1.2 to 2.0
equivalents of the enone starting material, the β-ketoboronate ester products 139 were
isolated in 62-82% yield with no B2pin2 contaminant. Finally, doubling the equivalents of
B2pin2 or NaOt-Bu were attempted and led to no improvements (Scheme 5-6).
Scheme 5-6. Diboration optimization

With successful diboration conditions in hand, the substrate scope was tested.
Terminal enone substrates were synthesized by 3 different methods depending on what our
starting material was (Scheme 5-7). The first method starts with a vinyl Grignard addition to
an aldehyde 143 to yield the allylic alocohol 144 followed by a Jones’ oxidation to give the
desired enone 99. The second method starts by creating a Weinreb amide 146 from an ester
145,49 followed by vinyl Grignard addition to the Weinreb amide 146 to give the
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corresponding enone 99.50 This technique was used on the more precious enones derived
from the more expensive Roche ester starting material. The final technique was used to
create dienones 149. It began with the addition of a vinyl Grignard to the vinyl aldehyde 147
to synthesize the diallyl alcohol 148. A tetrapropylammonium perruthenate (TPAP)
oxidation was required to oxidize the alcohol into the final dienone product 149.51
Scheme 5-7. Terminal enone synthesis

The enone products synthesized above were then subjected to the diboration
conditions in an attempt to understand the scope of this reaction (Scheme 5-8). In the top
row of products 139, 150-152, 1.2 equivalents of the enone was used in each case because
these enone substrates were less stable and prone to decomposition in the reaction mixture.
These substrates 139, 150-152 took 3 hours for the diboration to go to completetion. The
substrates in the second row 153-156 were derived from more expensive starting material
and required more steps to arrive at the enone making them more precious than the top row.
Luckily, enones 153-156 were much more stable than 139, 150-152 and were able to undergo
the diboration using 1.0 equivalents of the enone and 1.1 of B2pin2. It was even found that
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these substrates could be resubjected to the reaction conditions if they did not go to
completion in the first attempt. These substrates took 6 hours for the diboration to go to
completion, but were stable enough that they could be left overnight with no effect on the
yield. The last two substrates, 157 and 158, were dienone compounds that contain alkenes on
either side of the ketone, one being terminal and the other disubstituted 157 or trisubstituted
158. In the case of 157, the diboration proceeded in only 42% yield, but maintained ~90%
chemoselectivity for the terminal alkene over the disubstituted alkene. When the
trisubstituted substrate 158 was tested, 79% yield was obtained with 100% chemoselectivity
for the terminal enone.
Scheme 5-8. Testing the scope of enone diboration
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5.3 Oxidation of Carbon Boron Bond
Now that the β-ketoboronate esters were successfully synthesized in high yields,
oxidation procedures to obtain the desired β-hydroxyketone were screened. The common
oxidation conditions of H2O2 and NaOH stirring for an hour in THF led to little success for
the substrates tested (Scheme 5-9). These conditions were likely too harsh for the substrates
because little to no product was obtained and all of the starting material was gone.
Scheme 5-9. Initial oxidation attempts

After a quick literature search, an alternative and much milder oxidation using
sodium perborate tetrahydrate in a 1:1 mixture of THF and H2O was found.52 The first
attempt with this oxidation was with β-ketoboronate ester 139, which was oxidized to 159 in
71% yield in 3 hours. However, purification proved difficult for this substrate and the
product was isolated with a slight pinacol contaminant in the product (Scheme 5-10).
Pinacol is the byproduct from oxidizing a Bpin group.
Scheme 5-10. Successful oxidation52
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The scope of this oxidation was tested with the β-ketoboronate esters that were
previously synthesized. In most cases, excellent yields were obtained with this oxidation.
With the exception of 2 substrates that proved to be more difficult to work with than the rest,
all of the yields were 89% or higher (Scheme 5-11). Most products were isolated with no
trouble by column chromatography, however, a few had pinacol contaminants that could not
be removed by chromatography. However it was later found that the pinacol could be
removed by leaving the substrate on high vacuum at 45° C over-night.
Scheme 5-11. Oxidation results using NaBO3·4H2O

In an attempt to increase the yield of this sequence, the isolation of the βketoboronate ester was skipped and the crude product was taken directly through the
oxidation (Scheme 5-12). Boronate esters are known to decompose when in contact with
silica gel.53 The hydroxyl groups on the silica gel can interact with the empty p orbital of
boron and cause loss of the Bpin group.

This was attempted on two substrates, and in both
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cases it resulted in a higher yield over the two steps. Compound 160 obtained an 81% yield
without isolation of the β-ketoboronate ester intermediate, while with isolation of the
intermediate a combined yield of 61% was obtained. The 81% yield was calculated by mass
% from the 1H NMR since some pinacol contaminant was present, however we now know
that this pinacol contaminant can be removed via high vacuum. The hexanal derived
substrate 162 was also isolated in a higher 76% yield without isolation of the intermediate,
compared to a 58% yield with intermediate isolation.
Scheme 5-12. Direct diboration and oxidation
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6. Felkin Controlled Diastereoselective Hydrosilation
6.1 Diastereoselectivity of Hydrosilation
With a successful synthetic route for β-hydroxyketones, the next step was
hydrosilation of these new compounds. The idea behind this hydrosilation is that the methyl
group and the large group on the carbon alpha to the carbonyl 96 that is not on the transition
state ring will be able to control the diastereoselectivity of the proprionate product. The
diastereoselectivity of this reaction is expected to proceed through the Felkin-Ahn model 98
(Scheme 6-1).12 The Felkin-Ahn model is a well-known and widely accepted model for
addition to carbonyls. In the Felkin-Ahn model, the large R group on the alpha carbon is to
be perpendicular to the carbonyl and the medium methyl group is 120 degrees
counterclockwise from the large group 98.14 From the Felkin-Ahn model it is expected that
the anti-propionate product 97 will be synthesized (Scheme 6-1).
Scheme 6-1. Possible diastereoselective hydrosilation based on the Felkin-Ahn model

This hydrosilation produced varying results depending on the substrate used (Scheme
6-2). It was found that the R group had to be very large in order to give high
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diastereoselectivity, but too large of a group would shut down the reaction. When R = Ph
(167), the large group promoted high diastereoselectivity in the product, >9:1. However,
with 168, R = OTBS, the sterics interference is too large and hydrosilation prevented,
providing only starting material after desilylation. However, when a smaller alcohol
protecting group such as PMB 169 is used, no diastereoselectivity is obtained. Same as in
the case of 170, little diastereoselectivity is obtained with the PMB protection. Slightly
higher diastereoselectivity is obtained when the PMB protection is swapped for the larger
TBS as in 171, but diastereoselectivity is still minimal. Synthesis of anti-propionate subunits
via this Felkin-controlled hydrosilation did not prove to be very successful.
Scheme 6-2. Hydrosilation of various β-hydroxyketone substrates

58

6.2 Matched and Mismatched Hydrosilation and Substrate Synthesis
With multiple results of both syn-propionate synthesis via the methyl group inside TS
ring and anti-propionate synthesis via the Felkin controlled model, we were interested in
determining which methyl group had the stronger effect on selectivity. It was assumed that
the methyl group inside the transition state ring would have the higher selectivity based on
previous hydrosilation results (Scheme 3-15). To test this, the following two compounds
were synthesized and termed matched I and mismatched J (Figure 6-1).

Figure 6-1. Matched and mismatched substrates
The reasoning behind the names matched and mismatched is based off of the
stereocontrol that both of the methyl groups incorporate after the hydrosilation (Scheme 6-3).
The methyl group on the C1 carbon promotes anti-propionate synthesis while the methyl
group on the C2 carbon promotes syn-propionate synthesis. When the C1 and C2 methyl
groups are anti to each other in the β-hydroxyketone 172, this is termed the matched
compound because both methyl groups promote the same stereochemistry for the hydroxyl
group being formed (dashed in the case of 172). This will create the anti-syn stereotriad
(Scheme 6-3). When the two methyl groups are syn to each other, as in 173, the molecule is
termed mismatched, because one methyl groups promotes one diastereomer of product, while
the other methyl group promotes a different diastereomer (Figure 6-3).
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Scheme 6-3. Matched and mismatched hydrosilation

The synthesis of the matched and mismatched substrates proved to be challenging,
the mismatched in particular. Both substrates were derived from the (R)-Roche Ester 174, a
commercially available chiral starting material, because it already contains the methyl group
on the C1 carbon in a single enantiomer (Scheme 6-4). Obtaining the methyl group on the C2
carbon in a single enantiomer was the challenging part of this synthesis. After some time, we
settled on doing asymmetric aldol reactions on a protected ethyl ketone 177 derived from the
(R)-Roche Ester 174. Using different catalysts and bases, it is possible to have the enolate of
ethyl ketone 177 add into formaldehyde asymmetrically to give either the matched 175 or
mismatched 176 substrate (Scheme 6-4).
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Scheme 6-4. (R)-Roche Ester derived synthetic route for matched and mismatched
substrates

The first step in the ethyl ketone 177 synthesis was protecting the alcohol of (R)
Roche ester 174. A PMB protecting group was decided on based on the results from the
paper by Urpı and coworkers on asymmetric aldol reactions using this ethyl ketone.54 The
PMB protected ester 178 was synthesized in 94% yield by the addition of PMB acetimidate
to the Roche ester in DCM with a catalytic amount of CSA (Scheme 6-5).55 Next, the
Weinreb amide 179 was synthesized from the protected ester 178 by the addition of iPrMgCl to 178 and N,O-dimethylhydroxylamine in THF.49 The Weinreb amide is useful for
ketone synthesis because it allows for the addition of Grignard reagents directly to the
Weinreb amide to synthesize ketones.56 If the Grignard reagent was added directly to the
ester, it would add once, push off the ester group to create the ketone, then a second
equivalent of Grignard would add into the ketone giving an undesired product.1 When a
Grignard is added to the Weinreb amide, the intermediate 180 is produced, and this
intermediate is stable in the reaction mixture preventing a second Grignard addition. Upon
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aqueous workup, this intermediate collapses with loss of the amine group to give the desired
ketone 177 in 80% yield, 75% from 174 (Scheme 6-5).
Scheme 6-5. Ethyl ketone synthesis (references on slides)

The last step in synthesizing the matched and mismatched substrates involved
asymmetric aldol reactions with the enolate adding into formaldehyde (Scheme 6-6).
Formaldehyde is a gas that is particularly difficult to work with because in order to obtain
pure formaldehyde, it requires the pyrolysis of paraformaldehyde, the polymer of
formaldehyde. Once paraformaldehyde is pyrolyzed, the resulting formaldehyde is very
sensitive to moisture and when in contact with even the smallest amount of moisture it will
polymerize again. Extreme caution is required when working with formaldehyde to
minimize the moisture as much as possible.
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In the synthesis of the matched substrate 175, dicyclohexylboron chloride (Cy2BCl), a
very large reagent, is used with triethylamine, a small base, for preferential formation of the
E-enolate.49 Paraformaldehyde undergoes pyrolysis to yield pure formaldehyde gas which is
transferred via cannula to a solution of ether at -78° C. This formaldehyde solution is then
added to the enolate, which adds into formaldehyde via a chair like transition state 181. This
transition state allows for the methyl group to adopt the anti-position to the other methyl
group giving the matched substrate 175.49 The mismatched substrate is synthesized in a
similar manner, using (i-PrO)TiCl3 as the Lewis acid, a smaller Lewis acid, and a large base,
Hünig's base (i-Pr2EtN), promoting formation of the Z-enolate. The Z-enolate adds into
formaldehyde by the transition state 182.54 The difficulty with this reaction came from the
solubility of formaldehyde. At first, the reaction was attempted by pyrolyzing
paraformaldehyde into DCM then adding the DCM formaldehyde solution to the enolate, but
this was unsuccessful. The problem arose with solubility of formaldehyde in DCM, where it
tended to polymerize rather than dissolve in the DCM. However, when this was attempted
again with the enolate in DCM and formaldehyde in ether, decent success was obtained with
this reaction.
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Scheme 6-6. Asymmetric aldol reactions to synthesize the matched and mismatched
substrates

Now that both the matched 175 and mismatched 176 substrates had been synthesized,
the hydrosilation was attempted on these substrates. Both substrates resulted in good yields,
68% from the matched substrate and 72% from the mismatched (Scheme 6-7). As expected,
the C2 methyl group has greater control of the product stereochemistry. In both cases, the
syn-propionates were synthesized. The C1 methyl in the mismatched substrate did not have
any effect on the stereochemistry of the product. Both cases resulted in >10:1
diastereoselectivity of the syn-propionate by 1H NMR analysis. This is useful because it
allows synthesis of both the syn-syn-propionate subunit 184 along with the anti-synpropionate subunit 183 depending on whether matched or mismatched substrate is used.
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Scheme 6-7. Matched vs. mismatched hydrosilation

6.3 Reagent Purity and Silane Disproportionation
The leading cause of low yields or no reaction occurring from this hydrosilation is
due to impure reagents. Imidazole must be recrystallized from DCM prior to use and
triethylamine and DCM must be either distilled over calcium hydride to remove water or
obtained from a solvent system. It is often difficult to control the purity of the silane reagent
itself. It is required to distill the silane directly out of the bottle before use, but even after
distillation, it decomposes after a set amount of time, generally two to three weeks. At this
point, more silane must be distilled prior to use. After 4-5 months the bottle itself will go bad
and cause complete loss of activity even after distillation. Our prediction for the
decomposition is a disproportionation or redistribution of the groups on silicon.
Evidence for the rearrangement of silicon compounds has been shown by Forbes and
Anderson. They looked at the disproportionation of silicon trichlorothiocyanate 185 and its
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ability to form silicon tetrachloride 186 and silicon tetrathiocyanate 187 without the addition
of any catalyst (Scheme 6-8). It was found that after five months in a sealed tube at room
temperature, silicon trichlorothiocyanate 185 rearranged to the extent of 35%, meaning that
35% of 185 had transformed into a combination of 186 and 187 in a ratio of 3:1. After 19
months in a sealed tube at room temperature, 185 had been found to rearrange to the extent of
63%, leaving only 37% of 185 and the rest as a mixture of 186 and 187.57
Scheme 6-8. Disproportionation of silicon trichlorothiocyanate57

It is predicted that after a certain amount of time, our silane reagent,
diphenylchlorosilane 188, rearranges in a similar way. It is also thought that the electron rich
phenyl groups on silicon speed on this rearrangement by stabilizing the formation of a cation
or an anion on the silicon center. One of the proposed disproportionations is shown (Scheme
6-9), where a hydride from silane 188 adds into the silicon center of another molecule of 188
to give a positively charged tricoordinate silicon species 189 that is stabilized by electron
donation from the phenyl groups along with a negatively charged pentacoordinate silicon
190, also stabilized by the phenyl groups. From there, a phenyl group from 190 will migrate
to 189 to neutralize both silicon species and give the rearrangement products 191 and 192.
This is not the only way for silane 188 to rearrange; there are a variety of products that could
be produced from similar rearrangement (Scheme 6-10). It was attempted to monitor this
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rearrangement by 1H NMR, however this proved to be unsuccessful. Even after three weeks,
the spectra looked almost identical to directly after distillation however the silane did not
work in the hydrosilation reaction.
Scheme 6-9. Proposed disproportionation of Ph2SiHCl

Scheme 6-10. Possible rearrangement products
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7. Discodermolide
7.1 Isolation and Biological Properties
To show the synthetic utility of our hydrosilation reaction, we decided to continue on
from our matched hydrosilation product 183 to synthesize the stereocenters present in the
different fragments of (-)-discodermolide (Figure 7-1). Discodermolide is a highly studied
natural product because of its possible anti-cancer properties.58 Discodermolide was first
isolated in 1990 by Longley and coworkers from the marine sponge Discodermia dissolute.
This sponge was collected by scuba at Lucay in the Grand Bahama Island at a depth of 33
meters. After extracting the sponge with methanol and toluene, purifying the extract on silica
gel and reverse-phase chromatography, discodermolide was found in the ethyl acetate layer
in 0.002% yield (w/w from frozen sponge). They found that discodermolide itself was
unstable at room temperature on high vacuum, so it was required to synthesize the acetylated
version in order to characterize it and determine its structure.59

Figure 7-1. (+)-Discodermolide
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The main biological function of discodermolide is as a microtubule stabilizing agent.
Computer analysis of (+)-discodermolide has shown its potential as an antimitotic compound
and Day and coworkers have confirmed this prediction.60 Discodermolide is often compared
to Epothilone A and paclitaxel for its antimitotic activity. Unlike Epothilone A, which
inhibits microtubule formation Discodermolide works through the same mechanism as
paclitaxel by hyper-stabilizing microtubules.61 Specifically, discodermolide will cause
hyperstabilization of the mitotic spindle during mitosis causing cell cycle arrest and cell
death. Even with concentrations of discodermolide as low as 10 nM it could be seen that
filamentous and bundled microtubules were beginning to form and concentrating around the
nucleus. As the concentration of discodermolide was increased to 1 µM, the microtubule
bundles became increasingly prominent and elongated.60 Similarly, paclitaxel at 10 nM
concentration had essentially no effect on the microtubule network. Paclitaxel at 10 µM
concentration showed high levels of microtubule bundles, but they were still not as extensive
as 1 µM discodemolide, showing that discodermolide is a much more potent microtubule
stabilizing agent than paclitaxel.60
CA46 cells were used to further test the effect of discodermolide because these cells
arrest in the classic “C-mitosis” which is easy to see and quantify. The effects of increasing
discodermolide on the growth of these cells was tested and an IC50 value of 30 nM
discodermolide was obtained compared to 40 nM paclitaxel. At a 1 µM discodermolide
concentration, 68% of the cells were in mitotic arrest.60
The mechanism for the increased potency over paclitaxel was determined by
Schreiber and coworkers. It was found that both paclitaxel and discodermolide compete for
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the same binding location on β-tubulin, but not the same binding site, and discodermolide
binds this location much more strongly than paclitaxel. However, discodermolide and
paclitaxel bind β-tubulin at different binding sites. Paclitaxel binds the M-loop62 while
discodermolide interacts with the N-terminal H1-S2 loop.63 Knowing that they both bind in
different locations allows for discodermolide and paclitaxel to work together complementary,
which has been observed previously both in vitro and in vivo.63
The ability to hyper-stabilize cancer cell microtubules causing mitotic arrest is easy to
visualize as a possible cancer treatment and has been shown to destroy cancer cells.58 But it
has also been discovered that microtubule stabilizing molecules, such as discodermolide, are
possible cures for Alzheimer’s disease and other neurodegenerative diseases as well.
Microtubules form linear arrays in the axons of neuorons. The positive end is directed
towards the synapses of the neuron while the negative end is pointed towards the cell body.
The directionality and organization of these microtubules is important for proper function of
the nerve cell. This system, along with many other structures, is a part of the axonal
transport machinery. Taupathies are a group of neurodegenerative diseases, that include
Alzheimer’s disease, that are believed to involve lack of axonal transportation, specifically
involving the misfolding and aggregation of the microtubule associated protein tau.64
Aggregations of tau proteins cause buildup of amyloid plaques that are characteristic of
Alzheimer’s disease. With these finding, the idea of a microtubule stabilizing drug as a
potential cure for Alzheimer’s disease and other neurodegenerative diseases is a distinct
possibility.65
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Figure 7-2. Epothilone A and Paclitaxel
7.2 Previous Synthesis
With all the possible biological applications of discodermolide, it has become a
popular target for natural product synthesis. Both (+) and (-)-discodermolide have been
synthesized in multiple laboratories. The first laboratory to report the synthesis of (+)discodermolide, the naturally occurring enantiomer, was Schreiber’s.66 Prior to his synthesis
of (+)-discodermolide, he had reported the synthesis of its enantiomer, the unnatural (-)discodermolide.67 Since then, several other syntheses’ have been reported.68 The most
notable synthesis is the gram-scale synthesis by Smith and co-workers.69 This, along with
Patterson’s first generation synthesis70 permitted Novartis to synthesize 60 g of (+)discodermolide71 for phase I clinical trials.72 We will look at Smith’s synthesis of (-)discodermolide in more detail since our chemistry is on its way to synthesizing the (-)enantiomer of discodermolide.73
The retrosynthesis reported by Smith for (-)-discodermolide starts by breaking the
molecule into three different fragments, A, B and C (Scheme 7-1). These three fragments
can be further broken down into a single common precursor (CP).73 This common precursor
was of particular interest to us and our hydrosilation research. The common precursor
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contains a stereotriad with anti-syn stereochemistry, the exact same stereochemistry as the
anti-syn stereotriad that results from the hydrosilation of the matched substrate I. In our case
we happened to start with the (R)-roche ester for our matched and mismatched research, so
we will continue on with this enantiomer to create the stereocenters from (-)-discodermolide.
The enantiomer can be synthesized simply by starting with the (S)-roche ester instead of the
(R).
Scheme 7-1. Smith’s retrosynthesis of (-)-discodermolide73

Smith and coworkers synthesize the common precurser by starting with the (R)-roche
ester 174 and PMB protecting it followed by LiAlH4 reduction of the ester to an alcohol 193.
Next, an aldol was required to create the stereotraid so the alcohol was oxidized up to the
aldehyde 194 by a swern oxidation and an Evan’s aldol was performed to give the desired
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stereotriad 195. The oxazolidinone auxiliary was removed by formation of the Weinreb
amide and completion of CP (Scheme 7-2). Similarly, in our synthesis five steps are also
required to synthesize the stereotriad using a hydrosilation to set the hydroxyl stereocenter
(Scheme 7-3).
Scheme 7-2. Smith and coworkers CP synthesis

Scheme 7-3. Hydrosilation to synthesize the stereotriad

7.3 Fragment Synthesis
To show the synthetic utility of our hydrosilation reaction, we decided to continue on
from our common precursor 183 to synthesize the stereocenters present in the 3 fragments of
(-)-discodermolide. The stereocenters of A were synthesized by selectively oxidizing the
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primary alcohol into the aldehyde 186 via a TEMPO oxidation (Scheme 7-4). This was
achieved in 91% yield. Next, an Evan’s aldol was performed to give 197 in 85% yield with
the same stereopentad as fragment A. For fragment B, the stereotriad of our common
precursor 183 was the same, so no further reaction were needed. For fragment C, the four
stereocenters in the lactone ring were obtained after four reactions (Scheme 7-5). The first
reaction was an acetal protection of the 1,3-diol to form 198 in 97% yield. Next, the PMB
group was removed by addition of DDQ to give the alcohol 199 in 84% yield. Oxidation of
the primary alcohol via TEMPO provided aldehyde 200 in 82%. And finally, an asymmetric
allylation of the aldehyde using Leighton’s allylation reagent74 201 provided 202, which
contains the 4 stereocenters present in the lactone ring of fragment C.
Scheme 7-5. Synthesis of the stereopentad present in fragment A
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Scheme 7-6. Synthesis of the stereopentad present in fragment C
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8. Conclusion
The hydrosilation research was continued after a new synthetic route to obtain βhydroxyketones was discovered. This new route consisted of the diboration of terminal
enone compounds to the corresponding β-ketoboronate ester. Next, the carbon boron bond
was oxidized to provide the β-hyroxyketone in two steps from the enone. The diboration
proceeded in high yields, varying from 64% for the difficult substrates, up to the 80-95%
range where most substrates consisted. The oxidation proceeded in high 89-100% yields in
the majority of substrates, only a few outliers in the 70% range.
The hydrosilation to create anti-propionate subunits was tested and gave varying
results depending on the substrate. The diastereoselectivity was found to be much lower than
desired for most substrates. However, the matched and mismatched hydrosilation provided
great success, allowing synthesis of the anti-syn propionate from the matched substrate in
>10:1 diastereoselectivity along with the syn-syn propionate from the mismatched substrate
in >10:1 diastereoselectivity. This results shows that the methyl substituent inside the
transition state ring has complete control of the diastereoselectiviy of the product.
The stereotriad from the matched substrate 183 matched the common precursor CP
used by Smith and coworkers to synthesize (-)-discodermolide. We were able to take our
stereotriad and use it as a common precursor to synthesize all the stereocenters present in the
three fragments of (-)-discodermolide.
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9. Future Work
The next step in our research involves different ways of opening the cyclic disiloxane
ring rather than just completely removing it using TBAF. The current idea is to use t-BuLi in
place of TBAF and have the t-Bu group add to the silicon and break one of the oxygen
silicon bonds, essentially putting a diphenyl t-butyl silicon protection on one of the hydroxyl
groups (Scheme 9-1). This will allow for selective protection of one of the alcohol groups in
the propionate subunit without the additional step. It will be particularly useful to protect the
secondary alcohol in this manner because it is not currently possible to protect a secondary
alcohol in the presence of a primary alcohol.
Scheme 9-1. t-BuLi opening of the cyclic disiloxane

Additional future work involves the synthesis of the natural product Nhatrangin A
(Figure 9-1). Nhatrangin A has been shown to have anticancer activity against lymphocytic
murine leukemia (P-388).75 In vivo tests on mice revealed that microgam dosages were
enough to show increased survival time in mice injected with the P-388 leukemia cell line.76
In the main chain of Nhatrangin A, the anti-syn stereotriad that is produced from the matched
hydrosilation is present (Figure 9-1).

77

Figure 9-1. Structure of Nhatrangin A with stereotriad highlighted
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10. Experimental
Enone synthesis:
Enone synthesis from aldehydes:
Under an N2 atmosphere, the aldehyde (5.0 mmol) was dissolved in THF (12 mL) in a 50 mL
flame dried Schlenk tube and cooled to 0° C in an ice/water bath. A freshly made solution of
vinylmagnesium bromide (1.0 M, 6.0 mmol, 1.2 eq.) was added slowly and the reaction was
allowed to stir for 30 minutes. The reaction was quenched with a saturated ammonium
chloride solution. The aqueous layer was extracted with methyl tert-butyl ether (3 x 25 mL)
and the combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. The crude product was then dissolved in acetone (25 ml) and cooled
to 0° C. Jones reagent (4.0 M, 5.0 mmol, 1.0 eq.) was added dropwise and the reaction was
allowed to stir for 10 minutes before the addition of isopropanol (1 mL). Water (10 mL) was
added and the reaction mixture was extracted with methyl tert-butyl ether (3 x 25 mL) and
the combined organic layers were washed with a brine solution (25 mL), dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo.

Enone synthesis from weinreb amide:

(R)-5-((4-methoxybenzyl)oxy)-4-methylpent-1-en-3-one.
Under

an

N2

atmosphere,

(R)-N-methoxy-3-((4-methoxybenzyl)oxy)-N,2-

dimethylpropanamide (0.649 g, 2.43 mmol, 1 eq.) dissolved in THF (13 mL), was added to a
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50 mL flame dried Schlenk tube equipped with a stir bar and cooled to -15° C in an
acetone/ice bath. A freshly made solution of vinylmagnesium bromide (8.2 mL, 1.0 M, 8.21
mmol, 3.2 eq) was added dropwise. The reaction mixture was stirred and allowed to warm to
room temperature over 5 hours. The reaction was quenched with a saturated ammonium
chloride solution. The aqueous layer was extracted with methyl tert-butyl ether (3 x 25 mL)
and the combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. Purification by flash column chromatography on silica gel (4:1
hexanes:EtOAc) provided (R)-5-((4-methoxybenzyl)oxy)-4-methylpent-1-en-3-one as a clear
colorless oil (0.350 g, 1.50 mmol, 62%).

1

H NMR (500 MHz, chloroform-d):  = 7.22 (d, J = 9.0, 2H), 6.87 (d, J = 9.0, 2H), 6.44 (dd,

J = 11.0, 18.0, 1H), 6.28 (dd, J = 1.5, 18.0, 1H), 5.80 (dd, J = 1.5, 10.5, 1H), 4.4d (d, J =
11.0, 1H), 4.40 (d, J = 11.5, 1H), 3.80 (s, 3H), 3.67 (dd, J = 9.5, 2.0, 1H), 3.44 (dd, J = 8.5,
3.0, 1H), 3.17 (sextet, J = 6.0, 1H), 1.11 (d, J = 6.5, 3H).

13

C NMR (125 MHz, chloroform-

d): = 202.7, 159.4, 135.7, 130.4, 129.4, 128.6, 113.9, 73.1, 71.9, 55.5, 43.9, 14.1. IR
(neat): 2935, 2857, 1697, 1676, 1611, 1512, 1245, 1093, 1033, 972, 818 cm-1. HRMS (ESI)
calcd for (C14H18O3 + Na)+ 257.1154, found 257.1152. [α] = -9.25 (c = 9.8, CH2Cl2)

(R)-5-((tert-butyldimethylsilyl)oxy)-4-methylpent-1-en-3-one.
Under

an

N2

atmosphere,

(R)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N,2-

dimethylpropanamide (0.965 g, 3.74 mmol, 1 eq.) dissolved in THF (19 mL), was added to a
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50 mL flame dried Schlenk tube equipped with a stir bar and cooled to -15° C in an
acetone/ice bath. A freshly made solution of vinylmagnesium bromide (12.0 mL, 1.0 M,
12.0 mmol, 3.2 eq) was added dropwise. The reaction mixture was stirred and allowed to
warm to room temperature over 5 hours. The reaction was quenched with a saturated
ammonium chloride solution. The aqueous layer was extracted with methyl tert-butyl ether
(3 x 25 mL) and the combined organic layers were dried over anhydrous magnesium sulfate,
filtered and concentrated in vacuo. Purification by flash column chromatography on silica
gel (10:1 hexanes:EtOAc) provided (R)-5-((tert-butyldimethylsilyl)oxy)-4-methylpent-1-en3-one as a clear colorless oil (0.455 g, 2.00 mmol, 53%).

1

H NMR (500 MHz, chloroform-d):  = 6.45 (dd, J = 10.0, 17.5, 1H), 6.26 (dd, 1.5, 17.5,

1H), 5.79 (dd, J = 1.5, 10.5, 1H), 3.80 (dd, J = 7.5, 10.0, 1H), 3.62 (dd, J = 6.0, 9.5, 1H), 3.09
(sextet, J = 6.5, 1H), 1.07 (d, J = 7.0, 3H), 0.85 (s, 9h), 0.3 (s, 3H), 0.1 (s, 3H).

13

C NMR

(125 MHz, chloroform-d): = 203.5, 136.3, 128.3, 65.6, 46.0, 26.0, 18.4, 13.6, -5.3. IR
(neat): 2956, 2929, 2857, 1700, 1680, 1463, 1252, 1099, 834, 775 cm-1. HRMS (ESI) calcd
for (C12H24O2Si + Na)+ 251.1443, found 251.1443. [α] = -36.2 (c = 10.5, CH2Cl2)

(S)-4-((tert-butyldimethylsilyl)oxy)pent-1-en-3-one.
Under

an

N2

atmosphere,

(S)-2-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-

methylpropanamide (1.388 g, 5.62 mmol, 1 eq.) dissolved in THF (28 mL), was added to a
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100 mL flame dried Schlenk tube equipped with a stir bar and cooled to -15° C in an
acetone/ice bath. A freshly made solution of vinylmagnesium bromide (18.0 mL, 1.0 M,
18.0 mmol, 3.2 eq) was added dropwise. The reaction mixture was stirred and allowed to
warm to room temperature over 5 hours. The reaction was quenched with a saturated
ammonium chloride solution. The aqueous layer was extracted with methyl tert-butyl ether
(3 x 25 mL) and the combined organic layers were dried over anhydrous magnesium sulfate,
filtered and concentrated in vacuo. Purification by flash column chromatography on silica
gel (4:1 hexanes:EtOAc) provided (S)-4-((tert-butyldimethylsilyl)oxy)pent-1-en-3-one as a
clear colorless oil (0.679 g, 3.17 mmol, 57%).

1

H NMR (500 MHz, chloroform-d):  = 6.87 (dd, J = 11.0, 18.0, 1H), 6.40 (dd, J = 2.0, 17.5,

1H), 5.77 (dd, J = 2.0, 11.0, 1H), 4.29 (q, 6.5, 1H), 1.31 (d, J = 7.0, 3H), 0.90 (s, 9H), 0.07 (s,
3H), 0.06 (s, 3H).

(S)-4-((4-methoxybenzyl)oxy)pent-1-en-3-one.
Under an N2 atmosphere, (S)-N-methoxy-2-((4-methoxybenzyl)oxy)-N-methylpropanamide
(0.585 g, 2.31 mmol, 1 eq.) dissolved in THF (50 mL), was added to a 100 mL flame dried
Schlenk tube equipped with a stir bar and cooled to -15° C in an acetone/ice bath. A freshly
made solution of vinylmagnesium bromide (2.88 mL, 2.0 M, 5.75 mmol, 2.5 eq) was added
dropwise. The reaction mixture was stirred for 1 hour. The reaction was quenched with a
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saturated ammonium chloride solution. The aqueous layer was extracted with methyl tertbutyl ether (3 x 25 mL) and the combined organic layers were dried over anhydrous
magnesium sulfate, filtered and concentrated in vacuo.
chromatography

on

silica

gel

(4:1

Purification by flash column

hexanes:EtOAc)

provided

(S)-4-((4-

methoxybenzyl)oxy)pent-1-en-3-one as a clear colorless oil (0.329 g, 1.50 mmol, 65%).

1

H NMR (500 MHz, chloroform-d):  = 7.26 (d, J = 9.0, 2H), 6.88 (d, J = 9.0, 2H), 6.79 (dd,

J = 10.0, 17.0, 1H), 6.43 (dd, J = 2.0, 17.5, 1H), 5.80 (dd, J = 2.0, 11.0, 1H), 4.49 (d, J =
11.0, 1H), 4.38 (d, J = 11.0, 1H), 4.09 (q, J = 7.0, 1H), 3.81 (s, 3H), 1.36 (d, J = 7.5, 3H).
13

C NMR (125 MHz, chloroform-d): = 201.6, 159.4, 130.9, 129.8, 129.6, 129.5, 113.9,

79.5, 71.5, 55.3, 17.8. [α]

Neral.
Under an open air atmosphere, PhI(OAc)2 (2.30 g, 7.13 mmol, 1.1 eq.) and TEMPO (0.101 g,
0.65 mmol, 0.1 eq.) were dissolved in acetonitrile (6.5 mL) and pH 7.0 buffer (1.6 mL) in a
50 ml round bottom flash equipped with a stir bar and cooled to 0° C in an ice/water bath.
Nerol (1.135 mL, 6.48 mmol, 1.0 eq.) was added and the reaction was stirred for three hours
and allowed to warm to room temperature. The reaction was quenched with saturated
aqueous sodium thiosulfate (5 mL) and the layers were separated. The aqueous layer was
extracted with DCM (3 x 15 mL) and the combined organic layers were dried over anhydrous
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magnesium sulfate, filtered and concentrated in vacuo.

Purification by flash column

chromatography on silica gel (10:1 hexanes:EtOAc) provided Neral as a clear slightly red oil
(1.200 g, 6.48 mmol, >100% yield) with a small amount of PhI(OAc)2 contaminant. Was
used in next reaction without further purification.

1

H NMR (500 MHz, chloroform-d):  = 9.89 (d, J = 8.5, 1H), 5.88 (d, J = 8.0, 1H), 5.13-

5.07 (m, 1H), 2.58 (t, J = 7.5, 2H), 2.23 (q, J = 7.5, 2H), 1.98 (s, 3H), 1.68 (s, 3H), 1.59 (s,
3H).

(Z)-5,9-dimethyldeca-1,4,8-trien-3-ol.
Under an N2 atmosphere, semi-crude Neral (6.48 mmol, 1.0 eq.) was dissolved in THF (18
mL) in a flame dried 50 mL Schlenk tube and cooled to 0° C in an ice/water bath. Freshly
prepared vinylmagnesium bromide (8.5 mL, 1.5 M, 13.0 mmol, 2.0 eq.) was added slowly to
the reaction mixture and the reaction was allowed to stir for 30 minutes at 0° C. The reaction
was quenched with saturated aqueous ammonium chloride (25 mL) and the layers were
separated. The aqueous layer was extracted with MTBE (3 x 25 mL) and the combined
organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated in
vacuo.

Purification by flash column chromatography on silica gel (20:1 to 10:1

hexanes:EtOAc) provided (Z)-5,9-dimethyldeca-1,4,8-trien-3-ol as a clear colorless oil (1.10
g, 6.11 mmol, 94%).
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1

H NMR (500 MHz, chloroform-d):  = 5.88 (ddd, J = 5.5, 10.5, 17.5, 1H), 5.26-5.20 (m,

2H), 5.14-5.08 (m, 2H), 4.85 (t, J = 7.0, 1H), 2.18-2.08 (m, 4H), 1.75 (d, J = 1.5, 3H), 1.69
(s, 3H), 1.61 (s, 3H).

C NMR (125 MHz, chloroform-d): = 140.3, 139.6, 132.7, 126.9,

13

124.0, 114.5, 69.6, 32.6, 26.6, 25.9, 23.7, 17.9.

(E)-1-phenylpenta-1,4-dien-3-one.
Under an N2 atmosphere, 4Å molecular sieves were activated by flame drying three times in
a 50 mL Schlenk tube equipped with a stir bar. (E)-1-phenylpenta-1,4-dien-3-ol (0.800 g, 5.0
mmol, 1.0 eq.), DCM (32 mL), and acetonitrile (3.2 mL) were added to the molecular sieves.
N-methylmorpholine-N-oxide (0.880 g, 7.5 mmol, 1.5 eq.) was added and the reaction was
stirred for 5 minutes. Tetrapropylammonium perruthenate (0.176 g, 0.5 mmol, 0.1 eq.) was
added and the reaction was allowed to stir overnight. The reaction mixture was filtered
through a plug of silica with EtOAc and concentrated in vacuo. Purification by flash column
chromatography on silica gel provided (E)-1-phenylpenta-1,4-dien-3-one as a clear slightly
yellow oil (0.408 g, 2.6 mmol, 52%).

1

H NMR (500 MHz, chloroform-d):  = 7.69 (d, J = 16.0, 1H), 7.60-7.52 (m, 2H), 7.45-7.40

(m, 2H), 7.03 (d, J = 16.5, 1H), 6.78-6.70 (m, 1H), 6.40 (d, J = 17.5, 1H), 5.91 (d, J = 10.5,
1H).
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(Z)-5,9-dimethyldeca-1,4,8-trien-3-one.
Under an N2 atmosphere, 4Å molecular sieves were activated by flame drying three times in
a 50 mL Schlenk tube equipped with a stir bar. (Z)-5,9-dimethyldeca-1,4,8-trien-3-ol (0.360
g, 2.0 mmol, 1.0 eq.), DCM (13 mL), and acetonitrile (1.3 mL) were added to the molecular
sieves.

N-methylmorpholine-N-oxide (0.352 g, 3.0 mmol, 1.5 eq.) was added and the

reaction was stirred for 5 minutes. Tetrapropylammonium perruthenate (0.070 g, 0.20 mmol,
0.1 eq.) was added and the reaction was allowed to stir overnight. The reaction mixture was
filtered through a plug of silica with EtOAc and concentrated in vacuo. Purification by flash
column chromatography on silica gel provided (Z)-5,9-dimethyldeca-1,4,8-trien-3-one as a
clear slightly yellow oil (0.118 g, 0.66 mmol, 33%) along with (Z)-5,9-dimethyldeca-1,4,8trien-3-ol (0.198 g, 1.10 mmol, 55% of starting material recovered) providing a yield based
on recovered starting material of 74%.

1

H NMR (500 MHz, chloroform-d):  = 6.40 (dd, J = 9.5, 18.0, 1H), 6.25 (d, J = 1.5, 1H),

6.21 (dd, J = 1.0, 17.0, 1H), 5.73 (dd, J = 1.5, 11.0, 1H), 5.15 (tq, J = 1.5, 9.0, 1H), 2.61 (t,
7.5, 2H), 2.16 (q, J = 7.0, 2H), 1.93 (d, J = 1.5, 3H), 1.67 (d, J = 1.0, 3H), 1.63 (s, 3H).

13

C

NMR (125 MHz, chloroform-d): = 190.1, 161.0, 138.3, 132.2, 127, 123.7, 122.3, 34.2,
26.8, 25.9, 25.7, 17.6. IR (neat): 2968, 2915, 2856, 1724, 1661, 1674, 1622, 1601, 1447,
1400, 1376, 1243, 1117, 983, 959, 853, 713 cm-1.
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Enone diboration:

1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-one (139).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.20 eq.) and NaOt-Bu (0.020 g, 0.20
mmol, 0.20 eq), dissolved in THF (2.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.254 g, 1.0 mmol, 1.0 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before 1-phenylprop-2-en-1-one (0.158 g, 1.2 mmol, 1.2 eq.) and water (1.0 mL) were added
and the reaction was allowed to stir for 3 hours. The reaction mixture was quenched with a
saturated Brine solution (5 mL). The aqueous layer was extracted with ethyl acetate (3 x 15
mL) and the combined organic layers were dried over anhydrous magnesium sulfate, filtered
and concentrated in vacuo. Purification by flash column chromatography on silica gel (10:1
hexanes:Ethyl Acetate) provided 1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)propan-1-one as a clear colorless oil (0.166 g, 0.64 mmol, 64%).

1

H NMR (500 MHz, chloroform-d):  = 7.97 (d, J = 7.0, 2H), 7.54 (t, J = 7.5, 1H), 7.44 (t, J

= 7.5, 2H), 3.16 (t, J = 7.0, 2H), 1.25 (s, 12H), 1.07 (t, J = 7.0, 2H).

13

chloroform-d): = 200.8, 137.1, 133.0, 128.7, 128.2, 83.3, 33.9, 25.0.
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C NMR (125 MHz,
13

B NMR (160 MHz,

chloroform-d): = 33.6. IR (neat): 2977, 2933, 1685, 1379, 1371, 1316, 1221, 1144, 690
cm-1. HRMS (ESI) calcd for (C15H21BO3 + Na)+ 283.1484, found 283.1490.

4-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one (150).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.20 eq.) and NaOt-Bu (0.020 g, 0.20
mmol, 0.20 eq), dissolved in THF (2.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.254 g, 1.0 mmol, 1.0 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before 4-phenylpent-1-en-3-one (0.192 g, 1.2 mmol, 1.2 eq.) and water (1.0 mL) were added
and the reaction was allowed to stir for 3 hours. The reaction mixture was quenched with a
saturate Brine solution (5 mL). The aqueous layer was extracted with ethyl acetate (3 x 15
mL) and the combined organic layers were dried over anhydrous magnesium sulfate, filtered
and concentrated in vacuo. Purification by flash column chromatography on silica gel (10:1
hexanes:Ethyl Acetate) provided 4-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentan-3-one as a clear colorless oil (0.197 g, 0.68 mmol, 68%).

1

H NMR (500 MHz, chloroform-d):  = 7.31 (t, J = 7.5, 2H), 7.25-7.2 (m, 3H), 3.77 (q, J =

7.0, 1H), 2.59-2.45 (m, 2H), 1.38 (d, J = 7.0, 3H), 1.21 (s, 12H), 0.90-0.78 (m, 2H).
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13

C

NMR (125 MHz, chloroform-d): = 211.6, 141.2, 129.0, 128.1, 127.1, 83.2, 52.5, 36.3,
25.0, 24.9, 17.9.

B NMR (160 MHz, chloroform-d):  = 34.3. IR (neat): 2976, 2930,

11

1712, 1371, 1315, 1144, 699 cm-1. HRMS (ESI) calcd for (C17H25BO3 + Na)+ 311.1798,
found 311.1799.

5-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-one (151).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.030 g, 0.30 mmol, 0.20 eq.) and NaOt-Bu (0.030 g, 0.30
mmol, 0.20 eq), dissolved in THF (3.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.381 g, 1.5 mmol, 1.0 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before 5-methylhex-1-en-3-one (0.202 g, 1.8 mmol, 1.2 eq.) and water (1.5 mL) were added
and the reaction was allowed to stir for 3 hours. The reaction mixture was quenched with a
saturate Brine solution (5 mL). The aqueous layer was extracted with ethyl acetate (3 x 15
mL) and the combined organic layers were dried over anhydrous magnesium sulfate, filtered
and concentrated in vacuo. Purification by flash column chromatography on silica gel (10:1
hexanes:Ethyl Acetate) provided 5-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)hexan-3-one as a clear colorless oil (0.284 g, 0.79 mmol, 79%).
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1

H NMR (500 MHz, chloroform-d):  = 2.54 (t, J = 7.0, 2H), 2.26 (d, J = 6.5, 2H), 2.12

(septet, J = 6.5, 1H), 1.23 (s, 12H), 0.90 (d, J = 6.5, 6H), 0.88 (t, J = 6.5, 2H).
(125 MHz, chloroform-d): = 211.5, 83.2, 51.5, 38.4, 25.2, 25.0, 24.8, 22.8.

13

C NMR

11

B NMR (160

MHz, chloroform-d):  = 34.4. IR (neat): 2957, 1711, 1414, 1379, 1370, 1313, 1144, 968,
872, 844 cm-1. HRMS (ESI) calcd for (C13H25BO3 + Na)+ 263.1797, found 263.1791.

1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octan-3-one (152).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.20 eq.) and NaOt-Bu (0.020 g, 0.20
mmol, 0.20 eq), dissolved in THF (2.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.254 g, 1.0 mmol, 1.0 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before oct-1-en-3-one (0.151 g, 1.2 mmol, 1.2 eq.) and water (1.0 mL) were added and the
reaction was allowed to stir for 3 hours. The reaction mixture was quenched with a saturate
Brine solution (5 mL). The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and
the combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. Purification by flash column chromatography on silica gel (10:1
hexanes:Ethyl Acetate) provided 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octan-3-one
as a clear colorless oil (0.163 g, 0.64 mmol, 64%).
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1

H NMR (500 MHz, chloroform-d):  = 2.55 (t, J = 7.0, 2H), 2.37 (t, J = 7.5, 2H), 1.56

(quintet, J = 7.5, 2H), 1.33-1.23 (m, 4H), 1.23 (s, 12H), 0.90 (t, J = 7.0, 2H), 0.87 (t, J = 7.5,
C NMR (125 MHz, chloroform-d): = 212.0, 83.3, 42.4, 37.7, 31.6, 25.0, 24.0, 22.7,

3H).

13

14.1.

11

B NMR (160 MHz, chloroform-d):  = 34.4. IR (neat): 2931, 1712, 1378, 1313,

1145, 968, 841 cm-1. HRMS (ESI) calcd for (C14H27BO3 + Na)+ 277.1954, found 277.1943.

(R)-1-((4-methoxybenzyl)oxy)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentan-3-one (153).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.010 g, 0.10 mmol, 0.20 eq.) and NaOt-Bu (0.010 g, 0.10
mmol, 0.20 eq), dissolved in THF (1.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.127 g, 0.5 mmol, 1.0 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (R)-5-((4-methoxybenzyl)oxy)-4-methylpent-1-en-3-one (0.137 g, 0.6 mmol, 1.2 eq.)
and water (0.5 mL) were added and the reaction was allowed to stir for 3 hours. The reaction
mixture was quenched with a saturate Brine solution (5 mL). The aqueous layer was
extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. After three hours, the
reaction had not gone to completion, the enone was still present in the crude 1H NMR
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spectra. The crude product was resubjected to the same reaction conditions and the yield was
based off of the amount of enone used. Purification by flash column chromatography on
silica gel (10:1 to 4:1 hexanes:Ethyl Acetate) provided (R)-1-((4-methoxybenzyl)oxy)-2methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one as a clear colorless oil
(0.197 g, 0.54 mmol, 91%).

1

H NMR (500 MHz, chloroform-d):  = 7.22 (d, J = 9.0, 2H), 6.86 (d, J = 8.5, 2H), 4.42 (d, J

= 11.0, 1H), 4.38 (d, J = 11.0, 1H), 3.80 (s, 3H), 3.60 (dd, J = 8.0, 9.5, 1H), 3.40 (dd, J = 5.5,
9.0, 1H), 2.86 (sextet, J = 7.5, 1H), 2.64 (dt, J = 1.5, 7.0, 2H), 1.22 (s, 12H), 1.06 (d, J = 6.5,
3H), 0.93-0.86 (m, 2H).

13

C NMR (125 MHz, chloroform-d): = 213.8, 159.3, 130.5, 129.4,

113.9, 83.2, 73.1, 72.3, 55.5, 46.2, 37.3, 31.8, 25.2, 25.0, 25.0, 13.9.

11

B NMR (160 MHz,

chloroform-d):  = 34.2. IR (neat): 2976, 2933, 1711, 1612, 1513, 1371, 1245, 1144, 819
cm-1. HRMS (ESI) calcd for (C20H31BO5 + Na)+ 385.2166, found 385.2156. [α] = -20.3 (c =
10.8, CH2Cl2)

(R)-1-((tert-butyldimethylsilyl)oxy)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan2-yl)pentan-3-one (154).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.18 eq.) and NaOt-Bu (0.020 g, 0.20
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mmol, 0.18 eq.), dissolved in THF (4.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.334 g, 1.32 mmol, 1.1 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (R)-5-((tert-butyldimethylsilyl)oxy)-4-methylpent-1-en-3-one (0.250 g, 1.10 mmol,
1.0 eq.) and water (2.0 mL) were added and the reaction was allowed to stir for 8 hours. The
reaction mixture was quenched with a saturate Brine solution (5 mL). The aqueous layer was
extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (10:1 hexanes:Ethyl Acetate) provided (R)-1-((tertbutyldimethylsilyl)oxy)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3one as a clear colorless oil (0.367 g, 1.03 mmol, 94%).

1

H NMR (500 MHz, chloroform-d):  = 3.72 (dd, J = 10.0, 2.0, 1H), 3.56 (dd, J = 10.0, 4.0,

1H), 2.75 (sextet, J = 6.0, 1H), 2.64 (t, J = 7.0, 2H), 1.23 (s, 6H), 1.22 (s, 6H), 1.02 (d, J =
6.5, 3H), 0.92-0.86 (m, 2H), 0.86 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H).

13

C NMR (125 MHz,

chloroform-d): = 214.3, 83.2, 65.7, 48.5, 37.8, 26.0, 25.0, 24.9, 18.4, 13.4, -5.3.

11

B NMR

(160 MHz, chloroform-d):  = 33.7. IR (neat): 2929, 2858, 1714, 1379, 1371, 1313, 1145,
1097, 835, 775 cm-1. HRMS (ESI) calcd for (C18H37BO4Si + Na)+ 379.2456, found
379.2461. [α] = -21.1 (c = 10.3, CH2Cl2)
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(S)-4-((tert-butyldimethylsilyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentan-3-one (155).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.20 eq.) and NaOt-Bu (0.020 g, 0.20
mmol, 0.20 eq), dissolved in THF (2.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.280 g, 1.1 mmol, 1.1 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (S)-4-((tert-butyldimethylsilyl)oxy)pent-1-en-3-one (0.214 g, 1.00 mmol, 1.0 eq.) and
water (1.0 mL) were added and the reaction was allowed to stir for 8 hours. The reaction
mixture was quenched with a saturate Brine solution (5 mL). The aqueous layer was
extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (10:1 hexanes:Ethyl Acetate) provided (S)-4-((tertbutyldimethylsilyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one as a
clear colorless oil (0.270 g, 0.79 mmol, 79%).

1

H NMR (500 MHz, chloroform-d):  = 4.15 (q, J = 6.5, 1H), 2.73 (dddd, J = 6.5, 6.5, 19.5,

44.0, 2H), 1.27 (d, J = 7.0, 3H), 1.22 (s, 6H), 1.22 (s, 6H), 0.91 (s, 9H), 0.90-0.86 (m, 2H),
0.7 (s, 3H), 0.6 (s, 3H).

13

C NMR (125 MHz, chloroform-d): = 215.1, 83.2, 74.9, 32.3,
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26.0, 25.0, 25.0, 21.3, 18.3, -4.5, -4.9.

11

B NMR (160 MHz, chloroform-d):  = 33.4. IR

(neat): 2955, 2931, 2858, 1716, 1379, 1371, 1314, 1251, 1145, 834, 776 cm-1. HRMS (ESI)
calcd for (C17H35BO4Si + Na)+ 365.2299, found 365.2307. [α] = -6.8 (c = 10.7, CH2Cl2)

(S)-4-((4-methoxybenzyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3one (156).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.020 g, 0.20 mmol, 0.14 eq.) and NaOt-Bu (0.020 g, 0.14
mmol, 0.20 eq), dissolved in THF (3.5 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.406 g, 1.6 mmol, 1.1 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (S)-4-((4-methoxybenzyl)oxy)pent-1-en-3-one (0.320 g, 1.45 mmol, 1.0 eq.) and
water (1.7 mL) were added and the reaction was allowed to stir for 8 hours. The reaction
mixture was quenched with a saturate Brine solution (5 mL). The aqueous layer was
extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (4:1 hexanes:Ethyl Acetate) provided (S)-4-((4methoxybenzyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one as a clear
colorless oil (0.447 g, 1.29 mmol, 89%).
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1

H NMR (500 MHz, chloroform-d):  = 7.28 (d, J = 8.5, 2H), 6.88 (d, J = 9.0, 2H), 4.51 (d, J

= 11.0, 1H), 4.38 (d, J = 11.5, 2H), 3.93 (q, J = 7.0, 1H), 3.81 (s, 3H), 2.72 (t, J = 6.5, 2H),
1.32 (d, J = 7.0, 3H), 1.23 (s, 12H), 0.93 (t, J = 6.5, 2H).

13

C NMR (125 MHz, chloroform-

d): = 213.7, 159.2, 129.8, 129.5, 113.9, 83.1, 80.0, 71.4, 55.3, 32.4, 24.8, 24.8, 17.9. IR
(neat): 2977, 2934, 1714, 1612, 1513, 1379, 1370, 1314, 1244, 1144, 1034, 822 cm-1.

(E)-1-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-1-en-3-one (157).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.010 g, 0.10 mmol, 0.20 eq.) and NaOt-Bu (0.010 g, 0.10
mmol, 0.20 eq), dissolved in THF (2 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.140 g, 0.55 mmol, 1.1 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (E)-1-phenylpenta-1,4-dien-3-one (0.079 g, 0.50 mmol, 1.0 eq.) and water (1 mL)
were added and the reaction was allowed to stir for 8 hours. The reaction mixture was
quenched with a saturate Brine solution (5 mL). The aqueous layer was extracted with ethyl
acetate (3 x 15 mL) and the combined organic layers were dried over anhydrous magnesium
sulfate, filtered and concentrated in vacuo. Purification by flash column chromatography on
silica gel (10:1 hexanes:Ethyl Acetate) provided (S)-4-((4-methoxybenzyl)oxy)-1-(4,4,5,5tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one as a clear colorless oil (0.060 g, 0.21
mmol, 42%).
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1

H NMR (500 MHz, chloroform-d):  = 7.54 (m, 2H), 7.39 (m, 2H), 7.22 (m, 2H), 7.14 (m,

1H), 6.74 (d, J = 16.5, 1H), 2.86 (t, J = 7.5, 2H), 1.26-1.20 (m, 12H), 1.02 (t, J = 7.0, 2H),
0.90 (m, 2H).

(Z)-5,9-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)deca-4,8-dien-3-one
(158).
Under an N2 atmosphere, a 10 mL flame dried Schlenk tube equipped with a stir bar was
charged with Copper(I) Chloride (0.004 g, 0.04 mmol, 0.20 eq.) and NaOt-Bu (0.004 g, 0.04
mmol, 0.20 eq), dissolved in THF (1.0 mL), and allowed to stir at room temperature for 10
minutes. Bis(pinacolato)diboron (0.056 g, 0.22 mmol, 1.1 eq.) was added, causing the
reaction mixture to turn black. The reaction was stirred at room temperature for 10 minutes
before (Z)-5,9-dimethyldeca-1,4,8-trien-3-one (0.036 g, 0.20 mmol, 1.0 eq.) dissolved in
THF (1.0 mL) and water (1.0 mL) were added and the reaction was allowed to stir for 8
hours. The reaction mixture was quenched with a saturate Brine solution (5 mL). The
aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers
were dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo.
Purification by flash column chromatography on silica gel (10:1 hexanes:Ethyl Acetate)
provided (Z)-5,9-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)deca-4,8-dien-3one as a clear colorless oil (0.048 g, 0.16 mmol, 79%).
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1

H NMR (500 MHz, chloroform-d):  = 6.03 (d, J = 1.5, 1H), 5.13 (tq, J = 1.5, 7.5, 1H), 2.57

(q, J = 7.0, 4H), 2.12 (q, J = 8.5, 2H), 1.85 (d, J = 1.5, 3H), 1.67 (d, J = 1.0, 3H), 1.61 (s,
3H), 1.24 (s, 12H), 0.90 (t, J = 7.5, 2H).

13

C NMR (125 MHz, chloroform-d): = 200.6,

157.9, 131.9, 123.9, 123.6, 83.0, 39.0, 33.8, 26.8, 25.7, 25.6, 24.8, 17.7. IR (neat): 2975,
2927, 1687, 1620, 1443, 1414, 1371, 1310, 1243, 1145, 1093, 968, 842 cm-1.

Boronate ester oxidation:

3-hydroxy-1-phenylpropan-1-one (159).
In an open air atmosphere 1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1one (0.061 g, 0.24 mmol, 1.0 eq.) was dissolved in THF (1.3 mL) and H2O (1.3 mL) in a
scintillation vial. NaBO3∙4H2O (0.100 g, 1.25 mmol, 5.0 eq.) was added and the reaction was
stirred vigorously for 3 hours at room temperature. H2O (10 mL) was added to increase the
size of the aqueous layer and the aqueous and organic layers were separated. The aqueous
layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by
flash column chromatography on silica gel (1:1 hexanes:Ethyl Acetate) provided 3-hydroxy1-phenylpropan-1-one (0.025 g, 0.17 mmol, 71%, ~90% pure).
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1

H NMR (500 MHz, chloroform-d):  = 7.97 (d, J = 6.0, 2H), 7.59 (t, J = 6.0, 1H), 7.48 (t, J

= 7.0, 2H), 4.04 (t, J = 5.5, 2H), 3.24 (t, J = 5.0, 2H).

1-hydroxy-4-phenylpentan-3-one (160).
In an open air atmosphere 4-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3one (0.176 g, 0.61 mmol, 1.0 eq.) was dissolved in THF (3.0 mL) and H2O (3.0 mL) in a
scintillation vial. NaBO3∙4H2O (0.244 g, 3.05 mmol, 5.0 eq.) was added and the reaction was
stirred vigorously for 3 hours at room temperature. H2O (10 mL) was added to increase the
size of the aqueous layer and the aqueous and organic layers were separated. The aqueous
layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by
flash column chromatography on silica gel (1:1 hexanes:Ethyl Acetate) provided 1-hydroxy4-phenylpentan-3-one (0.097 g, 0.54 mmol, 89%).

1

H NMR (500 MHz, chloroform-d):  = 7.34 (t, J = 7.0, 2H), 7.28 (d, J = 7.0, 1H), 7.21 (d, J

= 7/0, 2H), 3.79-3.73 (m, 3H), 2.61 (t, J = 5.0, 2H), 1.41 (d, J = 6.5, 3H).

13

C NMR (125

MHz, chloroform-d): = 211.8, 140.1, 129.1, 127.9, 127.4, 58.1, 53.4, 42.7, 17.1.
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1-hydroxy-5-methylhexan-3-one (161).
In an open air atmosphere 5-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3one (0.276 g, 1.15 mmol, 1.0 eq.) was dissolved in THF (6.0 mL) and H2O (6.0 mL) in a
scintillation vial. NaBO3∙4H2O (0.460 g, 5.75 mmol, 5.0 eq.) was added and the reaction was
stirred vigorously for 3 hours at room temperature. H2O (10 mL) was added to increase the
size of the aqueous layer and the aqueous and organic layers were separated. The aqueous
layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by
flash column chromatography on silica gel (1:1 hexanes:Ethyl Acetate) provided 1-hydroxy5-methylhexan-3-one (0.110 g, 0.85 mmol, 74%).

1

H NMR (500 MHz, chloroform-d):  = 3.84 (t, J = 5.5, 2H), 2.65 (t, J = 5.5, 2H), 2.53

(broad s, 1H), 2.31 (d, J = 7.0, 2H), 2.15 (sep, J = 7.0, 1H), 0.92 (d, J = 6.5, 6H).

1-hydroxyoctan-3-one (162).
In an open air atmosphere 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octan-3-one (0.127
g, 0.5 mmol, 1.0 eq.) was dissolved in THF (2.5 mL) and H2O (2.5 mL) in a scintillation vial.
NaBO3∙4H2O (0.200 g, 2.5 mmol, 5.0 eq.) was added and the reaction was stirred vigorously
for 3 hours at room temperature. H2O (10 mL) was added to increase the size of the aqueous
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layer and the aqueous and organic layers were separated. The aqueous layer was extracted
with ethyl acetate (3 x 15 mL) and the combined organic layers were dried over anhydrous
magnesium sulfate, filtered and concentrated in vacuo. Purification by flash column
chromatography on silica gel (1:1 hexanes:Ethyl Acetate) provided 1-hydroxy-4phenylpentan-3-one (0.065 g, 0.45 mmol, 90%).

1

H NMR (500 MHz, chloroform-d):  = 3.84 (t, J = 5.5, 2H), 2.67 (t, J = 5.5, 2H), 2.43 (t, J

= 7.5, 2H), 1.58 (q, J = 7.5, 2H), 1.35-1.25 (m, 4H), 0.88 (t, J = 6.5, 3H).

13

C NMR (125

MHz, chloroform-d): = 212.2, 57.9, 44.2, 43.4, 31.3, 23.3, 22.4, 13.9.

(R)-5-hydroxy-1-((4-methoxybenzyl)oxy)-2-methylpentan-3-one (163).
In an open air atmosphere, (R)-1-((4-methoxybenzyl)oxy)-2-methyl-5-(4,4,5,5-tetramethyl1,3,2-dioxaborolan-2-yl)pentan-3-one (0.156 g, 0.43 mmol, 1.0 eq.) was dissolved in THF
(2.5 mL) and H2O (2.5 mL) in a scintillation vial. NaBO3∙4H2O (0.160 g, 2.00 mmol, 5.0
eq.) was added and the reaction was stirred vigorously for 3 hours at room temperature. H2O
(10 mL) was added to increase the size of the aqueous layer and the aqueous and organic
layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and
the combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. The reaction had not gone to completion by 1H NMR analysis. The
crude product was resubjected to the same reaction condition with 0.100 g of NaBO3∙4H2O
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until completion by TLC analysis. Purification by flash column chromatography on silica gel
(1:1 hexanes:Ethyl Acetate) provided (R)-5-hydroxy-1-((4-methoxybenzyl)oxy)-2methylpentan-3-one as a clear colorless oil (0.098 g, 0.39 mmol, 91%).
1

H NMR (500 MHz, chloroform-d):  = 7.21 (d, J = 9.0, 2H), 6.87 (d, J = 9.0, 2H), 4.43 (d, J

= 11.5, 1H), 4.40 (d, J = 11.5, 2H), 3.90-3.80 (m, 2H), 3.59 (dd, J = 8.5, 9.5, 1H), 3.47 (dd, J
= 7.0, 9.0, 1H), 2.89 (sex., J = 6.5, 1H), 2.76 (ddd, J = 4.0, 6.5, 17.5, 1H) 2.71 (ddd, J = 2.5,
4.5, 16.0, 1H), 2.56 (t, J = 6.5, 1H), 1.07 (d, J = 7.0, 3H).

13

C NMR (125 MHz, chloroform-

d): = 214.4, 159.3, 129.8, 129.3, 113.8, 73.0, 71.9, 58.1, 55.3, 46.7, 44.0, 24.9, 13.2. IR
(neat): 3430, 2937, 1707, 1612, 1512, 1459, 1364, 1302, 1245, 1173, 1076, 1032, 818 cm-1.
HRMS (ESI) calcd for (C14H20O4 + Na)+ 275.1259, found 275.1251.

(R)-1-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2-methylpentan-3-one (164).
In an open air atmosphere (R)-1-((tert-butyldimethylsilyl)oxy)-2-methyl-5-(4,4,5,5tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one (0.139 g, 0.39 mmol, 1.0 eq.) was
dissolved in THF (2.0 mL) and H2O (2.0 mL) in a scintillation vial. NaBO3∙4H2O (0.160 g,
2.0 mmol, 5.0 eq.) was added and the reaction was stirred vigorously for 7 hours at room
temperature. H2O (10 mL) was added to increase the size of the aqueous layer and the
aqueous and organic layers were separated. The aqueous layer was extracted with ethyl
acetate (3 x 15 mL) and the combined organic layers were dried over anhydrous magnesium
sulfate, filtered and concentrated in vacuo. Purification by flash column chromatography on
102

silica gel (4:1 to 1:1 hexanes:Ethyl Acetate) provided (R)-1-((tert-butyldimethylsilyl)oxy)-5hydroxy-2-methylpentan-3-one as a clear colorless oil (0.099 g, 0.39 mmol, 100%).

1

H NMR (500 MHz, chloroform-d):  = 3.90-3.78 (m, 2H), 3.74 (dd, J = 7.5, 9.5, 1H), 3.66

(dd, J = 5.0, 9.5, 1H), 2.83-2.68 (m, 3H), 2.57 (t, J = 6.5, 1H), 1.04 (d, J = 6.5, 3H), 0.86 (s,
9H), 0.04 (s, 3H), 0.03 (s, 3H).

13

C NMR (125 MHz, chloroform-d): = 215.2, 65.8, 58.3,

49.1, 44.6, 26.0, 18.4, 13.0, -5.4, -5.4. IR (neat): 3399, 2955, 2929, 2857, 1707, 1472, 1388,
1253, 1078, 834, 775 cm-1. HRMS (ESI) calcd for (C12H26O3Si + Na)+ 269.1549, found
269.1549. [α] = -34.5 (c = 8.4, CH2Cl2)

(S)-4-((tert-butyldimethylsilyl)oxy)-1-hydroxypentan-3-one (165).
In an open air atmosphere (S)-4-((tert-butyldimethylsilyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2dioxaborolan-2-yl)pentan-3-one (0.260 g, 0.76 mmol, 1.0 eq.) was dissolved in THF (3.8
mL) and H2O (3.8 mL) in a scintillation vial. NaBO3∙4H2O (0.304 g, 2.38 mmol, 5.0 eq.)
was added and the reaction was stirred vigorously for 5 hours at room temperature. H2O (10
mL) was added to increase the size of the aqueous layer and the aqueous and organic layers
were separated. The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the
combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. Purification by flash column chromatography on silica gel (4:1 to 1:1
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hexanes:Ethyl Acetate) provided (S)-4-((tert-butyldimethylsilyl)oxy)-1-hydroxypentan-3-one
as a clear colorless oil (0.173 g, 0.74 mmol, 98%).

1

H NMR (500 MHz, chloroform-d):  = 4.15 (q, J = 7.0, 1H), 3.86 (s, 2H), 2.85 (dddd, J =

5.0, 6.0, 19.0, 57.0, 2H), 2.42 (s, 1H), 1.29 (d, J = 7.0, 3H), 0.92 (s, 9H), 0.09 (s, 6H).

13

C

NMR (125 MHz, chloroform-d): = 215.5, 75.0, 57.9, 39.4, 25.9, 20.9, 18.2, -4.5, -4.9. IR
(neat): 3429, 1256, 2930, 2886, 2858, 1715, 1473, 1362, 1252, 1118, 832, 776 cm-1. HRMS
(ESI) calcd for (C11H24O3Si + Na)+ 255.1392, found 255.1386. [α] = -3.6 (c = 10.1, CH2Cl2)

(S)-1-hydroxy-4-((4-methoxybenzyl)oxy)pentan-3-one (166).
In an open air atmosphere (S)-4-((4-methoxybenzyl)oxy)-1-(4,4,5,5-tetramethyl-1,3,2dioxaborolan-2-yl)pentan-3-one (0.440 g, 1.26 mmol, 1.0 eq.) was dissolved in THF (7.0
mL) and H2O (7.0 mL) in a scintillation vial. NaBO3∙4H2O (0.500 g, 6.3 mmol, 5.0 eq.) was
added and the reaction was stirred vigorously for 5 hours at room temperature. H2O (10 mL)
was added to increase the size of the aqueous layer and the aqueous and organic layers were
separated. The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the combined
organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated in
vacuo. Purification by flash column chromatography on silica gel (1:1 hexanes:Ethyl
Acetate) followed by high vacuum at 45ºC to remove excess pinacol provided (S)-1-
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hydroxy-4-((4-methoxybenzyl)oxy)pentan-3-one as a clear colorless oil (0.271 g, 1.14 mmol,
90%).

1

H NMR (500 MHz, chloroform-d):  = 7.27 (d, J = 8.5, 2H), 6.89 (d, J = 9.0, 2H), 4.48 (s,

2H), 3.92 (q, J = 7.0, 1H), 3.86 (t, J = 5.5, 2H), 3.81 (s, 3H), 2.82 (dddd, J = 5.5, 11.0, 23.5,
33.0, 2H), 1.33 (d, J = 7.5, 3H).

13

C NMR (125 MHz, chloroform-d): = 214.0, 159.5,

129.5, 129.4, 113.9, 80.2, 71.6, 57.7, 55.3, 39.5, 17.2. IR (neat): 3429, 2937, 1713, 1612,
1513, 1245, 1091, 1030, 818 cm-1. [α] = -30.7 (c = 8.3, CH2Cl2).

Carbonyl Hydrosilation, antipropionate synthesis:

(3R,4S)-4-phenylpentane-1,3-diol/(3S,4R)-4-phenylpentane-1,3-diol (167).
Under an N2 atmosphere, 1-hydroxy-4-phenylpentan-3-one (0.088 g, 0.49 mmol, 1.0 eq.) was
dissolved in DCM (5 mL) in an oven dried 10 mL Schlenk tube equipped with a stir bar.
Triethylamine (0.410 mL, 2.94 mmol, 6.0 eq.), imidazole (0.266 g, 3.92 mmol, 8.0 eq.) and
diphenylchloro silane (0.290 mL, 1.48 mmol, 3.0 eq.) were added in that order to the
reaction. The reaction was allowed to stir overnight for at least 18 hours before it was
transferred to a 100 mL round bottom flask with 30 mL of hexanes and placed in the freezer
for 2 hours. The solution was filtered through a plug of celite to remove imidazole salts from
the reaction mixture. Hexanes were removed in vacuo and the crude product was used
without isolation in the next step.
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The crude product was dissolved in THF (3 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (4.5 mL, 1.0 M, 4.5 mmol, 9.0 eq.) was added dropwise and the
reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (1:1 hexanes:EtOAc) provided (3R,4S)-4phenylpentane-1,3-diol/(3S,4R)-4-phenylpentane-1,3-diol as a clear colorless oil (0.060g,
0.33 mmol, 68%) in >10:1 diastereoselectivity.

1

H NMR (500 MHz, chloroform-d):  = 7.38-7.30 (m, 2H), 7.26-7.19 (m, 3H), 3.95-3.80 (m,

3H), 2.79 (quintet, J = 7.0, 1H), 2.58 (broad s, 1H), 2.02 (broad s, 1H), 1.91-1.85 (m, 1H),
1.70-1.62 (m, 1H), 1.28 (d, J = 7.0, 3H).

13

C NMR (125 MHz, chloroform-d): = 143.2,

128.9, 128.8, 128.3, 128.0, 127.1, 62.0, 46.8, 35.8, 17.8 cm-1.

(3R,4S)-4-((4-methoxybenzyl)oxy)pentane-1,3-diol (169).
Under an N2 atmosphere, (S)-1-hydroxy-4-((4-methoxybenzyl)oxy)pentan-3-one (0.048 g,
0.20 mmol, 1.0 eq.) was dissolved in DCM (2 mL) in an oven dried 10 mL Schlenk tube
equipped with a stir bar. Triethylamine (0.167 mL, 1.20 mmol, 6.0 eq.), imidazole (0.109 g,
1.60 mmol, 8.0 eq.) and diphenylchloro silane (0.117 mL, 0.60 mmol, 3.0 eq.) were added in
that order to the reaction. The reaction was allowed to stir overnight for at least 18 hours
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before it was transferred to a 100 mL round bottom flask with 30 mL of hexanes and placed
in the freezer for 2 hours. The solution was filtered through a plug of celite to remove
imidazole salts from the reaction mixture. Hexanes were removed in vacuo and the crude
product was used without isolation in the next step.
The crude product was dissolved in THF (5 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (0.9 mL, 1.0 M, 0.9 mmol, 4.5 eq.) was added dropwise and the
reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (4:1 to 1:2 hexanes:EtOAc) provided (3R,4S)-4-((4methoxybenzyl)oxy)pentane-1,3-diol as a clear colorless oil (0.038g, 0.16 mmol, 83%) in
approximately a 1:1 mixture of diastereomers.

1

H NMR (500 MHz, chloroform-d):  = 7.25 (d, J = 9.0, 4H), 6.88 (d, J = 9.0, 4H), 4.60 (d, J

= 11.0, 1H), 4.55 (d, J = 11.0, 1H), 4.42 (d, J = 11.0, 1H), 4.36 (d, J = 11.5, 1H), 3.92-3.87
(m, 1H), 3.80 (s, 6H), 3.69-3.64 (m, 1H), 3.52-3.46 (m, 1H), 3.40 (q, J = 5.5, 1H), 1.75-1.62
(m, 4H), 1.17 (d, J = 6.5, 6H). ).

13

C NMR (125 MHz, chloroform-d): = 159.3, 159.2,

130.4, 130.2, 129.5, 129.3, 78.1, 76.8, 75.0, 73.3, 70.7, 70.4, 61.4, 61.2, 55.3, 34.3, 33.7,
15.3, 14.0. IR (neat): 3378, 2935, 1612, 1513, 1245, 1092, 1032, 821, 730 cm-1.
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(3S,4R)-5-((4-methoxybenzyl)oxy)-4-methylpentane-1,3-diol (170).
Under an N2 atmosphere, (R)-5-hydroxy-1-((4-methoxybenzyl)oxy)-2-methylpentan-3-one
(0.094 g, 0.37 mmol, 1.0 eq.) was dissolved in DCM (4 mL) in an oven dried 10 mL Schlenk
tube equipped with a stir bar. Triethylamine (0.300 mL, 2.14 mmol, 6.0 eq.), imidazole
(0.194 g, 2.90 mmol, 8.0 eq.) and diphenylchloro silane (0.210 mL, 1.07 mmol, 3.0 eq.) were
added in that order to the reaction. The reaction was allowed to stir overnight for at least 18
hours before it was transferred to a 100 mL round bottom flask with 30 mL of hexanes and
placed in the freezer for 2 hours. The solution was filtered through a plug of celite to remove
imidazole salts from the reaction mixture. Hexanes were removed in vacuo and the crude
product was used without isolation in the next step.
The crude product was dissolved in THF (5 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (1.6 mL, 1.0 M, 1.6 mmol, 4.5 eq.) was added dropwise and the
reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (1:3 hexanes:EtOAc) provided (3S,4R)-5-((4methoxybenzyl)oxy)-4-methylpentane-1,3-diol as a clear colorless oil (0.085g, 0.33 mmol,
90%) in approximately a 1:1 mixture of diastereomers.
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1

H NMR (500 MHz, chloroform-d):  = 7.24 (d, J = 7.5, 4H), 6.88 (d, J = 8.0, 4H), 4.44 (s,

2H), 4.43 (s, 2H), 4.11 (s, 1H), 3.98 (d, J = 10.0, 1H), 3.85-3.80 (m, 4H), 3.80 (2, 6H), 3.783.74 (m, 1H), 3.60 (dd, J = 3.5, 9.0, 1H), 3.50 (q, J = 7.0, 2H), 3.43 (t, J = 8.0, 1H), 3.33
(broad s, 1H), 3.18 (broad s, 1H), 2.93 (broad s, 1H), 1.94-1.86 (m, 2H), 1.80-1.63 (m, 4H),
1.56-1.51 (m, 1H), 0.92 (d, J = 7.0, 3H), 0.85 (d, J = 7.5, 3H).

13

C NMR (125 MHz,

chloroform-d): = 159.6, 159.5, 130.1, 129.8, 129.6, 129.5, 114.1, 114.1, 77.6, 75.4, 75.2,
74.3, 73.4, 73.4, 62.4, 61.9, 55.5, 38.7, 38.5, 36.2, 35.2, 29.9, 13.8, 11.6.

(3S,4R)-5-((tert-butyldimethylsilyl)oxy)-4-methylpentane-1,3-diol (171).
Under an N2 atmosphere, (R)-1-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2-methylpentan-3one (0.049 g, 0.20 mmol, 1.0 eq.) was dissolved in DCM (2 mL) in an oven dried 10 mL
Schlenk tube equipped with a stir bar. Triethylamine (0.167 mL, 1.20 mmol, 6.0 eq.),
imidazole (0.109 g, 1.60 mmol, 8.0 eq.) and diphenylchloro silane (0.117 mL, 0.60 mmol,
3.0 eq.) were added in that order to the reaction. The reaction was allowed to stir overnight
for at least 18 hours before it was transferred to a 100 mL round bottom flask with 30 mL of
hexanes and placed in the freezer for 2 hours. The solution was filtered through a plug of
celite to remove imidazole salts from the reaction mixture. Hexanes were removed in vacuo
and the crude product was used without isolation in the next step.
The crude product was dissolved in THF (5 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (0.9 mL, 1.0 M, 0.9 mmol, 4.5 eq.) was added dropwise and the
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reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (4:1 to 1:1 hexanes:EtOAc) provided (3S,4R)-5-((tertbutyldimethylsilyl)oxy)-4-methylpentane-1,3-diol as a clear colorless oil (0.041g, 0.17
mmol, 83%) in approximately a 1.6:1 mixture of diastereomers.

1

H NMR (500 MHz, chloroform-d):  = 4.49 (broad s, 2H), 4.03 (d, J = 11.0, 1H), 3.90-3.75

(m, 8H), 3.67 (dd, J = 6.0, 10.5, 2H), 3.57 (dd, J = 6.0, 9.5, 2H), 1.82-1.65 (m, 7H), 1.461.50 (m, 1H), 0.92 (d, J = 7.5, 3H), 0.89 (s, 18H), 0.82 (d, J = 6.5, 3H), 0.08 (s, 6H), 0.07 (s,
6H).

13

C NMR (125 MHz, chloroform-d): = 78.2, 75.9, 69.1, 69.3, 62.4, 61.9, 39.8, 39.4,

36.4, 35.4, 26.0, 26.0, 18.3, 18.3, 13.5, 11.1, -5.4, -5.5, -5.5. IR (neat): 3334, 2954, 2928,
2884, 2857, 1472, 1463, 1525, 1053, 8333, 774 cm-1. HRMS (ESI) calcd for (C12H28O3Si +
Na)+ 271.1705, found 271.1703.

Matched and Mismatched substrate synthesis:

(R)-methyl 3-((4-methoxybenzyl)oxy)-2-methylpropanoate (178).
Under an N2 atmosphere, (R)-methyl 3-hydroxy-2-methylpropanoate (2.22 mL, 20.0 mmol,
1.0 eq.) was dissolved in DCM (4 mL) in a flame dried 25 mL Schlenk tube.
Camphorsulfonic acid (0.930 g, 4.0 mmol, 0.2 eq.) was added and the reaction was stirred.
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Freshly synthesized 4-methoxybenzyl 2,2,2-trichloroacetimidate (15.0 mmol, 1.5 eq.) was
added with DCM (6 mL) and the reaction was stirred overnight. The reaction mixture was
diluted with MTBE (50 mL) and the organic layer was washed with saturated NaHCO3 (2 x
30 mL), water (2 x 30 mL), and brine (1 x 30 mL), dried over anhydrous magnesium sulfate,
filtered and concentrated in vacuo. Purification by flash column chromatography on silica
gel (10:1 hexanes:EtOAc) provided (R)-methyl 3-((4-methoxybenzyl)oxy)-2methylpropanoate as a clear slightly yellow oil (4.95 g, 20.0 mmol, quantitative yield).

1

H NMR (500 MHz, chloroform-d):  = 7.24 (d, J = 8.5, 2H), 6.87 (d, J = 9.0, 2H), 4.46 (d, J

= 11.0, 1H), 4.44 (d, J = 11.0, 1H), 3.80 (s, 3H), 3.69 (s, 3H), 3.62 (dd, J = 7.5, 9.0, 1H), 3.45
(dd, J = 6.0, 9.0, 1H), 2.77 (sex., J = 5.5, 1H), 1.16 (d, J = 7.0, 3H).

13

C NMR (125 MHz,

chloroform-d): = 175.4, 159.2, 130.2, 129.2, 113.7, 72.8, 71.6, 55.3, 51.7, 40.2, 14.0.

(R)-N-methoxy-3-((4-methoxybenzyl)oxy)-N,2-dimethylpropanamide (179).
Under an N2 atmosphere, provided (R)-methyl 3-((4-methoxybenzyl)oxy)-2methylpropanoate (20.0, 1.0 eq.) and N,O-dimethylhydroxylamine (4.1 g, 42.0 mmol, 2.1
eq.) were dissolved in THF (44 mL) in a 250 ml flame dried Schlenk tube and cooled to -20º
C in a monitored dry ice and acetone cold bath. Freshly prepared isopropylmagnesium
chloride (28.0 mL, 3.0 M, 84.0 mmol, 4.2 eq.) was added over 20 minutes and the reaction
was slowly warmed to 0º C in an ice/water bath and allowed to stir for an additional hour.
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The reaction mixture was quenched by the addition of saturated aqueous NH4Cl (40 mL),
extracted with MTBE (4 x 40 mL), DCM (4 x 40 mL), dried over anhydrous magnesium
sulfate, filtered and concentrated in vacuo to provide (R)-N-methoxy-3-((4methoxybenzyl)oxy)-N,2-dimethylpropanamide. The product was used crude in the next
reaction.

1

H NMR (500 MHz, chloroform-d):  = 7.23 (d, J = 8.5, 2H), 6.86 (d, J = 8.0, 2H), 4.48 (d, J

= 11.5, 1H), 4.40 (d, J = 12.0, 1H), 3.80 (s, 3H), 3.69 (s, 3H), 3.68 (t, J = 8.5, 1H), 3.39 (dd,
J = 6.0, 9.0, 1h), 3.20 (s, 3H), 1.10 (d, J = 6.5, 3H).

(R)-1-((4-methoxybenzyl)oxy)-2-methylpentan-3-one (177).
Under an N2 atmosphere, crude (R)-N-methoxy-3-((4-methoxybenzyl)oxy)-N,2dimethylpropanamide (20.0 mmol, 1.0 eq.) was dissolved in THF (140 mL) in a flame dried
250 mL Schlenk tube and cooled to 0º C in an ice bath. Ethylmagnesium bromide (13.3 mL,
3.0M, 40.0 mmol, 2.0 eq.) was added slowly over 5 minutes and the reaction was allowed to
stir until completion by TLC. After 45 minutes the reaction was completed by TLC. The
reaction was quenched with saturated aqueous NH4Cl (50 mL), extracted with MTBE (3 x 50
mL), dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo.
Purification by flash column chromatography on silica gel provided (R)-1-((4-
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methoxybenzyl)oxy)-2-methylpentan-3-one as a clear slightly yellow oil (4.06 g, 17.2 mmol,
86%).

1

H NMR (500 MHz, chloroform-d):  = 7.21 (d, J = 9.0, 2H), 6.87 (d, J = 9.0, 2H), 4.4 (d, J

= 11.0, 1H), 4.39 (d, J = 11.5, 2H), 3.80 (s, 3H), 3.59 (dd, J = 8.0, 9.5, 1H), 3.42 (dd, J = 5.5,
9.5, 1H), 2.85 (sex., J = 7.5, 1H), 2.50 (q, J = 7.5, 2H), 1.06 (d, J = 7.5, 3H), 1.03 (t, J = 7.0,
3H).

13

C NMR (125 MHz, chloroform-d): = 213.9, 159.2, 130.2, 129.2, 113.7, 72.9, 72.1,

55.3, 49.2, 46.2, 35.3, 13.7, 7.6.

(2R,4R)-1-hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentan-3-one (175).
Under an N2 atmosphere, dicyclohexylboron chloride (5.2 mL, 1.0 M, 5.2 mmol, 1.3 eq.) was
dissolved in diethyl ether (16 mL) in a 100 mL flame dried Schlenk Tube and cooled to 0º C
in an ice/water bath. Triethylamine (0.892 mL, 6.4 mmol, 1.6 eq.) was added followed by
(R)-1-((4-methoxybenzyl)oxy)-2-methylpentan-3-one (0.944 g, 4.0 mmol, 1.0 eq.) dissolved
in diethyl ether (8 mL). The reaction mixture was stirred for two hours then cooled to -78º C
in a dry ice/acetone bath. While the reaction mixture was stirring, a solution of
formaldehyde in diethyl ether was obtained by pyrolysis of dry paraformaldehyde (1.20 g, 40
mmol, 10.0 eq.), the resulting gas created being carried in a stream of N2 into a Schlenk tube
containing diethyl ether (16 mL) cooled to -78º C in a dry ice/acetone bath. The resulting
formaldehyde solution was then added to the reaction mixture at -78º C via cannula. After
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stirring for one hour at -78º C, the solution was warmed to 0º C before the addition of
methanol (16 mL) and pH 7.0 buffer (16 mL). Hydrogen peroxide (3.0 mL, 30% aqueous)
was added dropwise at 0º C then removed from the ice/water bath and stirred for 1 hour at
room temperature. The reaction mixture was extracted with DCM (3 x 50 mL), dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (10:1 to 1:1 hexanes:EtOAc) provided (2R,4R)-1hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentan-3-one as a clear colorless oil in
quantitative yield (1.10 g, 4.0 mmol, 100%) in approximately 20:1 diastereoseletivity.

1

H NMR (500 MHz, chloroform-d):  = 7.20 (d, J = 8.5, 2H), 6.87 (d, J = 9.0, 2H), 4.42 (d, J

= 11.5, 1H), 4.38 (d, J = 11.0, 2H), 3.80 (s, 3H), 3.79-3.75 (m, 1H), 3.69-3.62 (m, 2H), 3.42
(dd, J = 5.0, 9.0, 1H), 3.15-3.08 (m, 1H), 2.92-2.84 (m, 1H), 2.52 (t, J = 6.5, 1H), 1.10 (d, J =
7.5, 3H), 1.04 (d, J = 7.5, 3H).

13

C NMR (125 MHz, chloroform-d): = 217.4, 159.3, 129.7,

129.3, 113.8, 73.1, 72.2, 64.6, 55.3, 48.5, 44.1, 13.9, 12.7. IR (neat): 3398, 2972, 2936,
2877, 1707, 1612, 1512, 1245, 1173, 1085, 1030, 818 cm-1.

(2S,4R)-1-hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentan-3-one (176).
Under an N2 atmosphere, TiCl4 (3.36 mL, 1.0 M, 3.36 mmol, 0.84 eq.) was dissolved in
DCM (4 mL) in a flame dried 25 mL Schlenk Tube and cooled to 0º C in an ice/water bath.
Freshly distilled (i-PrO)4Ti (0.331 mL, 1.12 mmol, 0.28 eq.) was added dropwise and the
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solution was stirred for 10 minutes at 0º C followed by 10 minutes at room temperature.
Meanwhile, in a second 50 mL flame dried Schlenk tube, by (R)-1-((4-methoxybenzyl)oxy)2-methylpentan-3-one (0.944 g, 4.0 mmol, 1.0 eq.) was dissolved in DCM (8 mL) and cooled
to -78º C in a dry ice/acetone bath. The (i-PrO)TiCl3 solution in DCM was then transferred
via cannula to the second Schlenk tube. The solution was stirred for 2 minutes before iPr2NEt (0.766 mL, 4.4 mmol, 1.1 eq.) was added dropwise. The reaction was stirred for 30
minutes at -78º C. While the reaction mixture was stirring, a solution of formaldehyde in
diethyl ether was obtained by pyrolysis of dry paraformaldehyde (1.20 g, 40 mmol, 10.0 eq.),
the resulting gas created being carried in a stream of N2 into a Schlenk tube containing
diethyl ether (10 mL) cooled to -78º C in a dry ice/acetone bath. The resulting formaldehyde
solution was then added to the reaction mixture at -78º C via cannula and the reaction
mixture was allowed to stir for 1.5 hours at -78º C. The reaction was quenched with
saturated aqueous NH4Cl (20 mL) and stirred vigorously at room temperature for 5 minutes.
MTBE (40 mL) was added to dilute the organic layer and the organic layer was washed with
H2O (20 mL), saturated NaHCO3 (20 mL), and brine (20 mL). The aqueous layers were then
extracted with MTBE (3 x 50 mL) and the combined organic layers were dried over
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (10:1 to 1:1 hexanes:EtOAc) provided (2S,4R)-1hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentan-3-one as a clear colorless oil (0.620
g, 2.34 mmol, 56%) in a 4:1 mixture of diastereomers.
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1

H NMR (500 MHz, chloroform-d):  = 7.20 (d, J = 8.5, 2H), 6.87 (d, J = 8.5, 2H), 4.41 (d, J

= 11.5, 1H), 4.37 (d, J = 12.0, 2H), 3.80 (s, 3H), 3.79-3.75 (m, 1H), 3.69-3.62 (m, 2H), 3.45
(dd, J = 4.5, 8.0, 1H), 3.21-3.16 (m, 1H), 2.94-2.86 (m, 1H), 2.71 (t, J = 7.0, 1H), 1.08 (d, J =
7.5, 3H), 1.00 (d, J = 7.0, 3H).

13

C NMR (125 MHz, chloroform-d): = 217.6, 159.4, 129.5,

129.4, 113.9, 73.2, 73.0, 65.0, 55.2, 48.9, 45.1, 13.4, 12.7. IR (neat): 3447, 2970, 2934,
2877, 1707, 1612, 1513, 1458, 1362, 1302, 1245, 1087, 1032, 818 cm-1.

Matched and Mismatched hydrosiliation:

(2R,3S,4R)-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentane-1,3-diol (183).
Under an N2 atmosphere, (2R,4R)-1-hydroxy-5-((4-methoxybenzyl)oxy)-2,4dimethylpentan-3-one (0.053 g, 0.20 mmol, 1.0 eq.) was dissolved in DCM (2 mL) in an
oven dried 10 mL Schlenk tube equipped with a stir bar. Triethylamine (0.167 mL, 1.20
mmol, 6.0 eq.), imidazole (0.109 g, 1.60 mmol, 8.0 eq.) and diphenylchloro silane (0.117
mL, 0.60 mmol, 3.0 eq.) were added in that order to the reaction. The reaction was allowed
to stir overnight for at least 18 hours before it was transferred to a 100 mL round bottom
flask with 30 mL of hexanes and placed in the freezer for 2 hours. The solution was filtered
through a plug of celite to remove imidazole salts from the reaction mixture. Hexanes were
removed in vacuo and the crude product was used without isolation in the next step.
The crude product was dissolved in THF (5 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (0.9 mL, 1.0 M, 0.9 mmol, 4.5 eq.) was added dropwise and the
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reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (4:1 to 1:1 hexanes:EtOAc) provided (2R,3S,4R)-5-((4methoxybenzyl)oxy)-2,4-dimethylpentane-1,3-diol as a clear colorless oil (0.036g, 0.13
mmol, 68%) in approximately a 10:1 mixture of diastereomers.

1

H NMR (500 MHz, chloroform-d):  = 7.24 (d, J = 8.5, 2H), 6.88 (d, J = 9.0, 2H), 4.46 (s,

2H), 4.16 (s, 1H), 3.81 (s, 3h), 3.80-3.73 (m, 2H), 3.69-3.64 (m, 1H), 3.59 (dd, J = 4.0, 9.5,
1H), 3.45 (t, J = 9.0, 1H), 2.02-1.96 (m, 1H), 1.78-1.71 (m, 1H), 0.98 (d, J = 6.5, 3H), 0.76
(d, J = 6.5, 3H).

13

C NMR (125 MHz, chloroform-d): = 159.4, 129.4, 113.9, 76.5, 73.3,

55.3, 36.3, 35.8, 13.1, 8.7. IR (neat): 3264, 2969, 2935, 2890, 2870, 2839, 1612, 1514, 1299,
1247, 1058, 1039, 1025, 990, 817, 697 cm-1.

(2S,3R,4R)-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentane-1,3-diol (184).
Under an N2 atmosphere, (2S,4R)-1-hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentan3-one (0.053 g, 0.20 mmol, 1.0 eq.) was dissolved in DCM (2 mL) in an oven dried 10 mL
Schlenk tube equipped with a stir bar. Triethylamine (0.167 mL, 1.20 mmol, 6.0 eq.),
imidazole (0.109 g, 1.60 mmol, 8.0 eq.) and diphenylchloro silane (0.117 mL, 0.60 mmol,
3.0 eq.) were added in that order to the reaction. The reaction was allowed to stir overnight
117

for at least 18 hours before it was transferred to a 100 mL round bottom flask with 30 mL of
hexanes and placed in the freezer for 2 hours. The solution was filtered through a plug of
celite to remove imidazole salts from the reaction mixture. Hexanes were removed in vacuo
and the crude product was used without isolation in the next step.
The crude product was dissolved in THF (5 mL) in a flame dried 10 mL Schlenk tube under
an N2 atmosphere. TBAF (0.9 mL, 1.0 M, 0.9 mmol, 4.5 eq.) was added dropwise and the
reaction was stirred for 1 hour at room temperature. The reaction was quenched with a
saturated NH4Cl solution and the organic layer was extracted with EtOAc (3 x 15 mL), dried
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by flash
column chromatography on silica gel (4:1 to 1:1 hexanes:EtOAc) provided (2S,3S,4R)-5-((4methoxybenzyl)oxy)-2,4-dimethylpentane-1,3-diol as a clear colorless oil (0.038g, 0.14
mmol, 72%) in a greater than 10:1 mixture of diastereomers.

1

H NMR (500 MHz, chloroform-d):  = 7.23 (d, J = 8.0, 2H), 6.87 (d, J = 9.0, 2H), 4.42 (s,

2H), 3.80 (s, 3H), 3.78-3.70 (m, 2H), 3.64 (d, J = 5.0, 2H), 3.44 (d, J = 5.5, 2H), 1.96-1.90
(m, 1H), 1.84-1.78 (m, 1H), 1.03 (d, J = 7.0, 3H), 1.01 (d, J = 7.0, 3H).

13

C NMR (125

MHz, chloroform-d): = 159.2, 130.2, 129.4, 113.8, 74.4, 73.0, 67.2, 55.3, 37.7, 36.3, 12.3,
11.6. IR (neat): 3384, 2963, 2932, 2876, 1612, 1513, 1459, 1245, 1078, 1032, 972, 819 cm-1.
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Discodermolide stereopentad synthesis:

(2S,3R,4R)-3-hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentanal (196).
In an open air atmosphere, (2R,3S,4R)-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentane-1,3diol (0.054 g, 0.2 mmol, 1.0 eq.) was dissolved in DCM (2 mL) in a scintillation vial
equipped with a stir bar and cooled to 0° C in an ice/water bath. Saturated aqueous NaHCO3
(1.5 mL) was added and the reaction was stirred vigorously. Potassium bromide (0.0095 g,
0.08 mmol, 0.4 eq.), TEMPO (0.0031 g, 0.02 mmol, 0.1 eq.), and NaOCl (0.4 mL, 6% aq.,
0.4 mmol, 2.0 eq.) were added in that order. The reaction was monitored by TLC and had
gone to completion after 20 minutes. The reaction was quenched with water (10 mL),
extracted with DCM (3 x 10 mL), dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. Purification by flash column chromatography on silica gel (1:1
hexanes:EtOAc) provided (2S,3R,4R)-3-hydroxy-5-((4-methoxybenzyl)oxy)-2,4dimethylpentanal as a clear colorless oil (0.048 g, 0.18 mmol, 91%).

1

H NMR (500 MHz, chloroform-d):  = 9.74 (s, 1H), 7.24 (d, J = 8.5, 2H), 6.88 (d, J = 9.0,

2H), 4.46 (s, 2H), 4.09 (d, J = 9.0, 1H), 3.85 (s, 1H), 3.81 (s, 3H), 3.63 (dd, J = 4.0, 9.5, 1H),
3.50 (t, J = 9.5, 1H), 2.44 (qd, J = 2.5, 7.0, 1H), 2.10-1.96 (m, 1H), 1.14 (d, J = 7.0, 3H), 0.85
(d, J = 6.5, 3H).

13

C NMR (125 MHz, chloroform-d): = 205.0, 159.4, 129.5, 113.9, 75.6,

75.5, 73.3, 55.3, 49.3, 35.5, 13.4, 6.2.
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(S)-4-benzyl-3-((2S,3R,4S,5R,6R)-3,5-dihydroxy-7-((4-methoxybenzyl)oxy)-2,4,6trimethylheptanoyl)oxazolidin-2-one (197).
Under an N2 atmosphere, (S)-4-benzyl-3-propionyloxazolidin-2-one (0.114 g, 0.5 mmol, 2.5
eq.) was dissolved in DCM (3 mL) in a flame dried 10 mL Schlenk tube and cooled to 0° C
in an ice/water bath. TiCl4 (0.55 mL, 0.55 mmol, 2.75 eq.) was added dropwise and the
reaction was stirred for 5 minutes. i-Pr2NEt (0.087 mL, 0.5 mmol, 2.5 eq.) was added
dropwise and the reaction was stirred for 20 minutes. The reaction mixture was cooled to 78° C via a dry ice/acetone bath and N-Methyl-2-pyrrolidone (0.048 mL, 0.5 mmol, 2.5 eq.)
was added and the reaction was stirred for 10 minutes. (2S,3R,4R)-3-hydroxy-5-((4methoxybenzyl)oxy)-2,4-dimethylpentanal (0.046 g, 0.017 mmol, 1.0 eq.) dissolved in DCM
(3 mL) was added slowly and the reaction was stirred for 1 hour at -78° C before being
warmed to 0° C and stirred for an addition 2 hours. The reaction was quenched with
saturated aqueous NH4Cl (10 mL). The aqueous layer was extracted with DCM (3 x 15 mL)
and the combined organic layers were dried over anhydrous magnesium sulfate, filtered and
concentrated in vacuo. Purification by flash column chromatography on silica gel (4:1 to 1:1
hexanes:EtOAc) provided (S)-4-benzyl-3-((2S,3R,4S,5R,6R)-3,5-dihydroxy-7-((4methoxybenzyl)oxy)-2,4,6-trimethylheptanoyl)oxazolidin-2-one as a clear colorless oil
(0.072 g, 0.14 mmol, 85%) in a 4:1 mixture of diastereomers.
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1

H NMR (500 MHz, chloroform-d):  =7.33 (t, J = 7.5, 2H), 7.28 (d, J = 7.0, 1H), 7.25 (d, J

= 9.0, 2H), 7.21 (d, J = 8.5, 2H), 6.89 (d, J = 8.5, 2H), 4.69-4.65 (m, 1H), 4.49 (d, J = 12.0,
1H), 4.44 (d, J = 11.5, 1H), 4.22-4.16 (m, 2H), 4.14 (dd, J = 3.0, 9.5, 1H), 4.09 (q, J = 5.5,
1H), 4.02-3.95 (m, 2H), 3.80 (s, 3H), 3.62 (d, J = 5.5, 1H), 3.59 (dd, J = 4.0, 9.0, 1H), 3.48 (t,
J = 9.0, 1H0, 3.31 (dd, J = 3.5, 13.0, 1H), 2.63 (dd, J = 10.0, 13.0, 1H), 2.06-1.98 (m, 1H),
1.76 (qd, J = 2.0, 7.0, 1H), 1.29 (d, J = 7.0, 3H), 1.01 (d, J = 7.0, 3H), 0.73 (d, J = 7.0, 3H).
13

C NMR (125 MHz, chloroform-d): = 177.2, 159.4, 153.0, 135.3, 129.5, 129.4, 129.0,

127.4, 113.9, 76.6, 74.9, 73.3, 66.0, 40.5, 38.2, 36.5, 35.7, 13.0, 12.2, 9.7. IR (neat): 3446,
2968, 1775, 1697, 1612, 1513, 1454, 1382, 1363, 1245, 1209, 1100, 1077, 1032, 970, 910,
824, 760, 729, 701 cm-1.

Discodermolide stereotetrad synthesis:

(4R,5R)-4-((R)-1-((4-methoxybenzyl)oxy)propan-2-yl)-2,2,5-trimethyl-1,3-dioxane (198).
Under an N2 atmosphere, (2R,3S,4R)-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentane-1,3diol (0.107 g, 0.4 mmol, 1.0 eq.) was dissolved in DCM (4 mL) in a flame dried 10 mL
Schlenk tube and cooled to 0° C in an ice/water bath. Dimethoxypropane (4.9 mL, 40.0
mmol, 10.0 eq.) then Camphorsulfonic acid (0.009 g, 0.04 mmol, 0.1 eq.) were added and the
reaction was allowed to warm to room temperature as it stirred overnight. The reaction was
quenched with saturated aqueous NaHCO3 (10 mL). The aqueous layer was extracted with
121

DCM (3 x 15 mL) and the combined organic layers were dried over anhydrous magnesium
sulfate, filtered and concentrated in vacuo. Purification by flash column chromatography on
silica gel (20:1 to 10:1 hexanes:EtOAc) provided (4R,5R)-4-((R)-1-((4methoxybenzyl)oxy)propan-2-yl)-2,2,5-trimethyl-1,3-dioxane as a clear colorless oil (0.119
g, 0.39 mmol, 97%).

1

H NMR (500 MHz, chloroform-d):  = 7.25 (d, J = 8.5, 2H), 6.87 (d, J = 9.0, 2H), 4.45 (d, J

= 11.5, 1H), 4.38 (d, J = 11.5, 2H), 4.08 (dd, J = 3.0, 11.0, 1H), 3.80 (s, 3H), 3.75 (dd, J =
2.5, 10.0, 1H), 3.60 (dd, J = 1.5, 12.0, 1H), 3.50, (dd, J = 3.0, 9.0, 1H), 3.40 (dd, J = 6.0, 8.5,
1H), 1.81-1.75 (m, 1H), 1.55-1.49 (m, 1H), 1.38 (s, 3H), 1.37 (s, 3H), 1.05 (d, J = 7.0, 3H),
0.91 (d, J = 7.0, 3H).

C NMR (125 MHz, chloroform-d): = 159.0, 131.0, 129.1, 113.7,

13

98.6, 72.8, 72.2, 71.7, 67.3, 55.3, 35.4, 29.8, 29.6, 22.9, 19.1, 12.6, 10.2. IR (neat): 2964,
2934, 2856, 1613, 1513, 1459, 1378, 1364, 1245, 1098, 1008, 847, 821 cm-1.

(R)-2-((4R,5R)-2,2,5-trimethyl-1,3-dioxan-4-yl)propan-1-ol (199).
Under an N2 atmosphere, (4R,5R)-4-((R)-1-((4-methoxybenzyl)oxy)propan-2-yl)-2,2,5trimethyl-1,3-dioxane (0.108 g, 0.35 mmol, 1.0 eq.) was dissolved in DCM (4 mL) and pH
7.0 buffer (4 mL) in a 25 ml Schlenk tube and cooled to 0° C in an ice/water bath. 2,3Dichloro-5,6-dicyano-1,4-benzoquinone (0.113 g, 0.5 mmol, 1.5 eq.) was added and the
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reaction was monitored by TLC for completion. After 1 hour the reaction was complete and
diluted with DCM (10 mL) and pH 7.0 buffer (10 mL) and the layers were separated. The
aqueous layer was extracted with DCM (3 x 15 mL) and the combined organic layers were
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification by
flash column chromatography on silica gel (10:1 to 4:1 hexanes:EtOAc) provided (R)-2((4R,5R)-2,2,5-trimethyl-1,3-dioxan-4-yl)propan-1-ol as a clear colorless oil (0.055g, 0.29
mmol, 84%).

1

H NMR (500 MHz, chloroform-d):  = 4.12 (dd, J = 3.0, 12.0, 1H), 3.82 (dd, J = 2.5, 10.0,

1H), 3.61 (dd, J = 1.5, 11.0, 1H), 3.60-3.52 (m, 2H), 3.10 (d, J = 7.5, 1H), 1.92-1.84 (m, 1H),
1.58-1.52 (m, 1H), 1.48 (s, 3H), 1.40 (s, 3H), 1.10 (d, J = 6.5, 3H), 0.76 (d, J = 7.0, 3H).

13

C

NMR (125 MHz, chloroform-d): = 98.7, 78.4, 69.0, 67.0, 36.4, 30.0, 29.7, 19.1, 12.0, 10.5.
IR (neat): 3436, 2965, 2936, 2876, 1460, 1379, 1269, 1246, 1198, 1094, 1035, 1007, 957,
847, 749 cm-1.

(S)-2-((4S,5R)-2,2,5-trimethyl-1,3-dioxan-4-yl)propanal (200).
In an open air atmosphere (R)-2-((4R,5R)-2,2,5-trimethyl-1,3-dioxan-4-yl)propan-1-ol
(0.062 g, 0.33 mmol, 1.0 eq.) was dissolved in DCM (3 mL) in a scintillation vial equipped
with a stir bar and cooled to 0° C in an ice/water bath. Saturated aqueous NaHCO3 (2.5 mL)
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was added and the reaction was stirred vigorously. Potassium bromide (0.016 g, 0.13 mmol,
0.4 eq.), TEMPO (0.0052 g, 0.033 mmol, 0.1 eq.), and NaOCl (0.7 mL, 6% aq., 0.66 mmol,
2.0 eq.) were added in that order. The reaction was monitored by TLC and had gone to
completion after 60 minutes. The reaction was quenched with water (10 mL), extracted with
DCM (3 x 10 mL), dried over anhydrous magnesium sulfate, filtered and concentrated in
vacuo. Purification by flash column chromatography on silica gel (1:1 hexanes:EtOAc)
provided (2S,3R,4R)-3-hydroxy-5-((4-methoxybenzyl)oxy)-2,4-dimethylpentanal as a clear
colorless oil (0.050 g, 0.27 mmol, 82%).

1

H NMR (500 MHz, chloroform-d):  = 9.73 (d, J = 2.5, 1H), 4.17-4.90 (m, 3H), 3.65 (dd, J

= 1.0, 21.0, 1H), 2.53-2.46 (m, 2H), 1.43 (s, 3H), 1.37 (s, 3H), 1.11 (d, J = 6.5, 3H), 0.95 (d,
J = 7.5, 3H).
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